Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer

Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also known as Nfe2l2) plays a critical role in regulating cellular defense against electrophilic and oxidative stress by activating the expression of an array of antioxidant response element-dependent genes. On one hand, NRF2 activators have bee...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 1843; no. 9; pp. 1875 - 1885
Main Authors Namani, Akhileshwar, Li, Yulong, Wang, Xiu Jun, Tang, Xiuwen
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also known as Nfe2l2) plays a critical role in regulating cellular defense against electrophilic and oxidative stress by activating the expression of an array of antioxidant response element-dependent genes. On one hand, NRF2 activators have been used in clinical trials for cancer prevention and the treatment of diseases associated with oxidative stress; on the other hand, constitutive activation of NRF2 in many types of tumors contributes to the survival and growth of cancer cells, as well as resistance to anticancer therapy. In this review, we provide an overview of the NRF2 signaling pathway and discuss its role in carcinogenesis. We also introduce the inhibition of NRF2 by nuclear receptors. Further, we address the biological significance of regulation of the NRF2 signaling pathway by nuclear receptors in health and disease. Finally, we discuss the possible impact of NRF2 inhibition by nuclear receptors on cancer therapy. •KEAP1–NRF2–ARE pathway•Role of NRF2 in cancer chemoprevention and carcinogenesis•Repression of NRF2 by nuclear receptors•Therapeutic perspective of NRF2 inhibition through nuclear receptors
AbstractList Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also known as Nfe2l2) plays a critical role in regulating cellular defense against electrophilic and oxidative stress by activating the expression of an array of antioxidant response element-dependent genes. On one hand, NRF2 activators have been used in clinical trials for cancer prevention and the treatment of diseases associated with oxidative stress; on the other hand, constitutive activation of NRF2 in many types of tumors contributes to the survival and growth of cancer cells, as well as resistance to anticancer therapy. In this review, we provide an overview of the NRF2 signaling pathway and discuss its role in carcinogenesis. We also introduce the inhibition of NRF2 by nuclear receptors. Further, we address the biological significance of regulation of the NRF2 signaling pathway by nuclear receptors in health and disease. Finally, we discuss the possible impact of NRF2 inhibition by nuclear receptors on cancer therapy. •KEAP1–NRF2–ARE pathway•Role of NRF2 in cancer chemoprevention and carcinogenesis•Repression of NRF2 by nuclear receptors•Therapeutic perspective of NRF2 inhibition through nuclear receptors
Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also known as Nfe2l2) plays a critical role in regulating cellular defense against electrophilic and oxidative stress by activating the expression of an array of antioxidant response element-dependent genes. On one hand, NRF2 activators have been used in clinical trials for cancer prevention and the treatment of diseases associated with oxidative stress; on the other hand, constitutive activation of NRF2 in many types of tumors contributes to the survival and growth of cancer cells, as well as resistance to anticancer therapy. In this review, we provide an overview of the NRF2 signaling pathway and discuss its role in carcinogenesis. We also introduce the inhibition of NRF2 by nuclear receptors. Further, we address the biological significance of regulation of the NRF2 signaling pathway by nuclear receptors in health and disease. Finally, we discuss the possible impact of NRF2 inhibition by nuclear receptors on cancer therapy.
Author Wang, Xiu Jun
Tang, Xiuwen
Li, Yulong
Namani, Akhileshwar
Author_xml – sequence: 1
  givenname: Akhileshwar
  surname: Namani
  fullname: Namani, Akhileshwar
  organization: Department of Biochemistry and Genetics, Zhejiang University School of Medicine, Hangzhou 310058, PR China
– sequence: 2
  givenname: Yulong
  surname: Li
  fullname: Li, Yulong
  organization: Department of Biochemistry and Genetics, Zhejiang University School of Medicine, Hangzhou 310058, PR China
– sequence: 3
  givenname: Xiu Jun
  orcidid: 0000-0001-7516-4606
  surname: Wang
  fullname: Wang, Xiu Jun
  email: xjwang@zju.edu.cn
  organization: Department of Pharmacology, Zhejiang University School of Medicine, Hangzhou 310058, PR China
– sequence: 4
  givenname: Xiuwen
  surname: Tang
  fullname: Tang, Xiuwen
  email: xiuwentang@zju.edu.cn
  organization: Department of Biochemistry and Genetics, Zhejiang University School of Medicine, Hangzhou 310058, PR China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24851839$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1OwzAQhC1URH_gDRDyCyQ4tuM4HJBQRaFSAamCs-X4p7hKk8hOQX17XAIc2cteZnZnvikYNW1jALjMUJqhjF1v06qSO-VTjDKaojxFiJyAScaLMsF5yUZgEmVFQjkvx2AawhbFoUV-BsaY8jzjpJyA9VOr97XsXdvA1sLn9QLD4DaNrF2zgZ3s3z_lAVYH2OxVbaSH3ijT9a0PN3C562qnvr0B2tZDJRtl_Dk4tbIO5uJnz8Db4v51_pisXh6W87tVoijmfcIlY5VGpmTYlJiQDHNFYyhTyYJgUjDLNJGUKamZtYxazbAulcxJKbVFBZkBOtxVvg3BGys673bSH0SGxBGR2IoBkTgiEigXEVG0XQ22bl_tjP4z_TKJgttBYGL4D2e8CMqZ2Ey7WL4XunX_f_gCO2p7wQ
CitedBy_id crossref_primary_10_1186_s12885_017_3907_z
crossref_primary_10_1016_j_abb_2019_108184
crossref_primary_10_1016_j_freeradbiomed_2024_06_008
crossref_primary_10_1016_j_lfs_2018_06_028
crossref_primary_10_1016_j_pestbp_2023_105627
crossref_primary_10_5937_mp73_35557
crossref_primary_10_3390_cancers12051090
crossref_primary_10_3390_molecules21040496
crossref_primary_10_1016_j_freeradbiomed_2022_09_014
crossref_primary_10_2174_2211536610666210716153929
crossref_primary_10_3390_ijms22094376
crossref_primary_10_1016_j_pharep_2016_12_011
crossref_primary_10_1021_acs_jpcb_8b03295
crossref_primary_10_2131_jts_47_89
crossref_primary_10_3390_molecules190710074
crossref_primary_10_1021_acs_jmedchem_8b01121
crossref_primary_10_1038_srep16889
crossref_primary_10_1016_j_abb_2023_109601
crossref_primary_10_3390_antiox13020193
crossref_primary_10_3390_biomedicines8050122
crossref_primary_10_3389_fphar_2018_01308
crossref_primary_10_3389_fphar_2022_807125
crossref_primary_10_1016_j_freeradbiomed_2015_06_037
crossref_primary_10_1111_cpr_12206
crossref_primary_10_32604_or_2022_026302
crossref_primary_10_1016_j_toxlet_2015_07_004
crossref_primary_10_1016_j_freeradbiomed_2021_12_001
crossref_primary_10_3390_cancers11111755
crossref_primary_10_1371_journal_pone_0239367
crossref_primary_10_1016_j_bcp_2020_114002
crossref_primary_10_37349_etat_2021_00040
crossref_primary_10_1016_j_ejmech_2015_08_049
crossref_primary_10_1016_j_bbadis_2016_11_005
crossref_primary_10_14336_AD_2018_0513
crossref_primary_10_1016_j_bbamcr_2018_02_010
crossref_primary_10_1016_j_taap_2015_08_006
crossref_primary_10_3390_ijms25137011
crossref_primary_10_1016_j_tips_2021_06_005
crossref_primary_10_1016_j_omto_2018_10_002
crossref_primary_10_3390_biom10050791
crossref_primary_10_1007_s10585_019_09988_9
crossref_primary_10_1007_s12079_014_0248_4
crossref_primary_10_1002_1873_3468_12779
crossref_primary_10_1074_jbc_M115_664953
crossref_primary_10_1002_cmdc_201700677
crossref_primary_10_1038_tp_2016_117
crossref_primary_10_3390_ijms20082025
crossref_primary_10_1016_j_lfs_2020_119015
crossref_primary_10_18632_aging_103068
crossref_primary_10_1016_j_biopha_2023_115855
crossref_primary_10_1155_2019_7180284
crossref_primary_10_1155_2017_1864578
crossref_primary_10_1016_j_redox_2018_11_017
crossref_primary_10_1080_13543776_2020_1715365
crossref_primary_10_1089_jmf_2022_0113
crossref_primary_10_1186_s12964_022_00906_3
crossref_primary_10_3390_ijms20225800
crossref_primary_10_1177_0976500X221128855
crossref_primary_10_18632_oncotarget_19349
crossref_primary_10_3892_ol_2018_9382
crossref_primary_10_1002_ags3_12814
crossref_primary_10_1021_np501007n
crossref_primary_10_3390_molecules26092424
crossref_primary_10_1016_j_neuint_2022_105325
crossref_primary_10_1146_annurev_pharmtox_010818_021856
crossref_primary_10_3390_cells11081266
crossref_primary_10_1039_C6MD00500D
crossref_primary_10_3390_ijms20051006
crossref_primary_10_1016_j_canlet_2019_09_016
crossref_primary_10_1002_1873_3468_14289
crossref_primary_10_18632_oncotarget_2833
crossref_primary_10_1007_s40495_017_0101_6
crossref_primary_10_1002_jcp_29219
crossref_primary_10_1089_ars_2018_7505
Cites_doi 10.1016/j.addr.2010.07.003
10.1007/s10549-010-1023-8
10.1128/MCB.00753-07
10.1038/nrd1551
10.1016/j.freeradbiomed.2012.12.014
10.1007/BF03401947
10.1371/journal.pmed.0030420
10.1016/j.bbamcr.2012.06.012
10.1016/j.bbrc.2007.08.051
10.1091/mbc.E12-09-0666
10.1128/MCB.24.17.7681-7694.2004
10.1016/j.bbrc.2011.09.014
10.1097/IGC.0b013e31822d0eb2
10.1053/j.gastro.2008.06.082
10.1038/onc.2012.388
10.1371/journal.pone.0073794
10.1172/JCI66353
10.1016/j.molcel.2009.04.029
10.1016/j.freeradbiomed.2007.03.001
10.2174/156802612799436641
10.1124/pr.58.4.4
10.1128/MCB.01704-07
10.1124/pr.58.4.2
10.1038/nrd2397
10.1158/0008-5472.CAN-09-2223
10.1089/ars.2011.4414
10.1073/pnas.93.25.14960
10.1038/sj.onc.1204506
10.1006/geno.1994.1193
10.1158/1078-0432.CCR-08-2822
10.1074/jbc.M403061200
10.1593/neo.11750
10.1089/ars.2010.3221
10.1158/0008-5472.CAN-07-5003
10.1126/science.1133427
10.1101/gr.2160004
10.1016/j.devcel.2007.07.011
10.1046/j.1365-2443.2001.00469.x
10.1101/gad.13.1.76
10.1128/MCB.26.8.2887-2900.2006
10.1006/bbrc.1997.6943
10.1038/sj.onc.1210986
10.1007/s11095-010-0096-8
10.1016/j.jmb.2007.11.074
10.1002/path.2653
10.1242/jcs.095422
10.1038/onc.2012.493
10.1073/pnas.1014275108
10.1038/ncb2021
10.1074/jbc.M110.118976
10.1124/pr.58.4.9
10.1007/s00280-009-1140-4
10.1074/jbc.M109.096545
10.1128/MCB.25.10.4150-4165.2005
10.1128/MCB.24.24.10941-10953.2004
10.1093/nar/gks409
10.1038/nm.3159
10.1210/en.2003-0817
10.2174/15680266113139990006
10.1074/jbc.M605707200
10.1158/1535-7163.MCT-09-0589
10.1158/0008-5472.CAN-12-4400
10.1016/j.mod.2004.01.006
10.1111/j.1755-148X.2011.00913.x
10.4161/epi.6.3.14408
10.1038/jhg.2010.172
10.1016/S1043-2760(02)00592-1
10.1007/s00018-008-7452-4
10.1073/pnas.1000102107
10.1038/nature10888
10.1093/carcin/bgm049
10.1007/s11033-011-1266-4
10.1128/MCB.25.1.162-171.2005
10.1093/carcin/bgq105
10.1074/jbc.M110.121913
10.1073/pnas.051618798
10.1073/pnas.0709483104
10.1002/med.21257
10.1016/j.cbi.2013.08.008
10.1016/j.bbrc.2008.06.004
10.1074/jbc.M111.316471
10.1016/j.jaci.2013.09.007
10.1016/j.mce.2005.08.002
10.1172/JCI27987
10.1186/1471-2407-12-66
10.2174/156652407781695765
10.1158/1535-7163.MCT-05-0497
10.1016/j.abb.2004.10.012
10.1158/0008-5472.CAN-06-0300
10.1016/j.freeradbiomed.2011.03.008
10.1038/42022
10.1016/j.bbalip.2011.09.014
10.1089/ars.2010.3222
10.1016/j.ccr.2012.05.016
10.1128/MCB.06271-11
10.1038/375203a0
10.1038/cdd.2010.114
10.1073/pnas.220418997
10.1073/pnas.0806268105
10.1128/MCB.25.24.10895-10906.2005
10.1074/jbc.M109.051714
10.2174/156802612799436687
10.1038/331091a0
10.1074/jbc.M602746200
10.1093/nar/gkq212
10.1128/MCB.00708-09
10.1371/journal.pone.0036774
10.1016/j.bbamcr.2008.05.024
10.1016/j.mce.2007.08.011
10.1089/ars.2010.3219
10.1073/pnas.172398899
10.1158/0008-5472.CAN-08-1401
10.1007/s10549-011-1604-1
10.1158/1535-7163.MCT-10-0108
10.2174/092986711795029618
10.1073/pnas.91.21.9926
10.1021/tx7002883
10.1074/jbc.M002319200
10.1158/0008-5472.CAN-12-3386
10.1146/annurev.med.53.082901.104018
10.1128/MCB.00248-10
10.1074/jbc.M500166200
10.1186/1477-3163-5-14
10.1016/j.gassur.2004.02.007
10.1158/0008-5472.CAN-04-1906
10.1074/jbc.M206530200
10.1074/jbc.M111.312694
10.1158/0008-5472.CAN-10-0384
10.1016/j.mce.2010.06.018
10.1128/MCB.01204-10
10.1158/1535-7163.MCT-08-0625
10.4161/epi.23319
10.1038/onc.2012.59
10.1038/nature10189
10.1074/jbc.M111.275495
10.1124/pr.58.4.7
10.1182/blood-2009-04-214817
10.1016/j.tips.2013.04.005
10.1093/carcin/bgt108
10.1073/pnas.0307301101
10.1093/carcin/bgn095
10.1016/j.mce.2011.08.033
10.1530/JME-13-0150
10.1002/jbt.20212
10.1016/j.taap.2013.03.029
10.1016/j.mce.2011.07.025
10.1128/MCB.00065-13
10.1006/taap.2001.9176
10.1093/carcin/bgi006
10.1021/tx0502138
10.1146/annurev.physiol.69.031905.160308
10.1016/j.freeradbiomed.2010.09.006
10.4161/epi.6.6.15773
10.1111/j.1439-0396.2008.00838.x
10.1158/0008-5472.CAN-07-2170
10.1016/j.molcel.2006.01.013
ContentType Journal Article
Copyright 2014 Elsevier B.V.
Copyright © 2014 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2014 Elsevier B.V.
– notice: Copyright © 2014 Elsevier B.V. All rights reserved.
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1016/j.bbamcr.2014.05.003
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1879-2596
EndPage 1885
ExternalDocumentID 10_1016_j_bbamcr_2014_05_003
24851839
S0167488914001505
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6I.
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABVKL
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AEXQZ
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
IXB
J1W
KOM
LX3
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OK1
OZT
P-8
P-9
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
ZE2
~G-
-~X
.55
.GJ
AACTN
AAYJJ
ABJNI
AFFNX
AI.
AKRWK
CGR
CUY
CVF
ECM
EIF
F5P
H~9
K-O
MVM
NPM
OHT
TWZ
UHS
VH1
X7M
Y6R
YYP
ZGI
~KM
0SF
AAXKI
AAYXX
ADVLN
AFJKZ
CITATION
ID FETCH-LOGICAL-c428t-8a66bd0e962e9233128c4183eba732376f6d3a46cad6ff64fd62d9ca539adf073
IEDL.DBID ABVKL
ISSN 0167-4889
0006-3002
IngestDate Thu Sep 26 19:52:43 EDT 2024
Tue Aug 27 13:50:16 EDT 2024
Fri Feb 23 02:31:00 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Bcl-2
RAR
Nuclear receptor
Neh7
RXRα
DBD
KEAP1
ChIP
TXS
BBN
DPP3
CBP
NRF2
PPAR
SNP
miRNA
11β-HSD1
GSH
NQO1
Bach1
ERα
GST
GR
β-TrCP
AKR1C
ERRβ
Neh
Bcl-xL
ARE
Dex
Cancer therapy
ROS
SMRT
ATRA
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
Copyright © 2014 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c428t-8a66bd0e962e9233128c4183eba732376f6d3a46cad6ff64fd62d9ca539adf073
ORCID 0000-0001-7516-4606
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0167488914001505
PMID 24851839
PageCount 11
ParticipantIDs crossref_primary_10_1016_j_bbamcr_2014_05_003
pubmed_primary_24851839
elsevier_sciencedirect_doi_10_1016_j_bbamcr_2014_05_003
PublicationCentury 2000
PublicationDate 2014-09-01
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta
PublicationTitleAlternate Biochim Biophys Acta
PublicationYear 2014
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Chorley, Campbell, Wang, Karaca, Sambandan, Bangura, Xue, Pi, Kleeberger, Bell (bb0275) 2012; 40
Sjoblom, Jones, Wood, Parsons, Lin, Barber, Mandelker, Leary, Ptak, Silliman, Szabo, Buckhaults, Farrell, Meeh, Markowitz, Willis, Dawson, Willson, Gazdar, Hartigan, Wu, Liu, Parmigiani, Park, Bachman, Papadopoulos, Vogelstein, Kinzler, Velculescu (bb0435) 2006; 314
Moi, Chan, Asunis, Cao, Kan (bb0020) 1994; 91
Hong, Freeman, Liebler (bb0175) 2005; 18
Kim, Yu, Chen, Kong (bb0110) 2013; 32
Hatcher, Planalp, Cho, Torti, Torti (bb0330) 2008; 65
Gronemeyer, Gustafsson, Laudet (bb0795) 2004; 3
Hanada, Takahata, Zhou, Ye, Sun, Itoh, Ishiguro, Kijima, Mimura, Itoh, Fukuda, Saijo (bb0475) 2012; 12
Rada, Rojo, Chowdhry, McMahon, Hayes, Cuadrado (bb0125) 2011; 31
Berger, Moller (bb0595) 2002; 53
Plafker, Nguyen, Barneche, Mirza, Crawford, Plafker (bb0085) 2010; 285
Apopa, He, Ma (bb0210) 2008; 22
Boesch-Saadatmandi, Wagner, Graeser, Hundhausen, Wolffram, Rimbach (bb0760) 2009; 93
Suzuki, Shibata, Takaya, Shiraishi, Kohno, Kunitoh, Tsuta, Furuta, Goto, Hosoda, Sakamoto, Motohashi, Yamamoto (bb0485) 2013; 33
Kundu, Surh (bb0030) 2010; 27
Satoh, Moriguchi, Taguchi, Takai, Maher, Suzuki, Winnard, Raman, Ebina, Nukiwa, Yamamoto (bb0315) 2010; 31
Brown, Sekhar, Rachakonda, Sasi, Freeman (bb0745) 2008; 68
Germain, Staels, Dacquet, Spedding, Laudet (bb0495) 2006; 58
Ohta, Iijima, Miyamoto, Nakahara, Tanaka, Ohtsuji, Suzuki, Kobayashi, Yokota, Sakiyama, Shibata, Yamamoto, Hirohashi (bb0430) 2008; 68
Jain, Lamark, Sjottem, Larsen, Awuh, Overvatn, McMahon, Hayes, Johansen (bb0230) 2010; 285
Yu, Wong, Wang, Ling, Ng, Chen, Chan (bb0665) 2008; 27
Katoh, Iida, Kang, Kobayashi, Mizukami, Tong, McMahon, Hayes, Itoh, Yamamoto (bb0095) 2005; 433
Dhakshinamoorthy, Jaiswal (bb0140) 2001; 20
Huang, Nguyen, Pickett (bb0195) 2000; 97
Furukawa, Xiong (bb0050) 2005; 25
Thimmulappa, Mai, Srisuma, Kensler, Yamamoto, Biswal (bb0025) 2002; 62
Watson, Fairall, Schwabe (bb0550) 2012; 348
Zhang, Singh, Yegnasubramanian, Esopi, Kombairaju, Bodas, Wu, Bova, Biswal (bb0385) 2010; 9
Muscarella, Barbano, D'Angelo, Copetti, Coco, Balsamo, la Torre, Notarangelo, Troiano, Parisi, Icolaro, Catapano, Valori, Pellegrini, Merla, Carella, Fazio, Parrella (bb0470) 2011; 6
Dawson, Xia (bb0585) 2012; 1821
Venugopal, Jaiswal (bb0285) 1996; 93
Helsen, Kerkhofs, Clinckemalie, Spans, Laurent, Boonen, Vanderschueren, Claessens (bb0700) 2012; 348
Singh, Wu, Zhang, Happel, Ma, Biswal (bb0345) 2010; 9
Shibata, Kokubu, Saito, Narisawa-Saito, Sasaki, Aoyagi, Yoshimatsu, Tachimori, Kushima, Kiyono, Yamamoto (bb0405) 2011; 13
Bushue, Wan (bb0535) 2010; 62
Ahmadian, Suh, Hah, Liddle, Atkins, Downes, Evans (bb0600) 2013; 19
Kim, Oh, Kim, Kang, Park, Han, Eom, Yoo, Lee (bb0400) 2010; 220
Germain, Chambon, Eichele, Evans, Lazar, Leid, De Lera, Lotan, Mangelsdorf, Gronemeyer (bb0575) 2006; 58
Ohnuma, Matsumoto, Itoi, Kawana, Nishiyama, Ogura, Hiratsuka (bb0775) 2011; 413
Gao, Ke, Wang, Yang, Chen, Chen (bb0780) 2013; 34
McMahon, Thomas, Itoh, Yamamoto, Hayes (bb0120) 2004; 279
Wakabayashi, Dinkova-Kostova, Holtzclaw, Kang, Kobayashi, Yamamoto, Kensler, Talalay (bb0065) 2004; 101
Lau, Wang, Zhao, Villeneuve, Wu, Jiang, Sun, White, Zhang (bb0235) 2010; 30
Giguere, Yang, Segui, Evans (bb0640) 1988; 331
Muscarella, Parrella, D'Alessandro, la Torre, Barbano, Fontana, Tancredi, Guarnieri, Balsamo, Coco, Copetti, Pellegrini, De Bonis, Bisceglia, Scaramuzzi, Maiello, Valori, Merla, Vendemiale, Fazio (bb0465) 2011; 6
Qu, Tang (bb0590) 2010; 65
Li, Huang, Yi, Bambara, Hilf, Muyan (bb0610) 2004; 24
Krishnan, Nair, Pillai (bb0725) 2007; 7
Hu, Ju, Lin, Wang, Huang, Zhang, Wu, Jiao (bb0415) 2012; 39
Giguere (bb0645) 2002; 13
Hayes, McMahon, Chowdhry, Dinkova-Kostova (bb0150) 2010; 13
Homma, Ishii, Morishima, Yamadori, Matsuno, Haraguchi, Kikuchi, Satoh, Sakamoto, Hizawa, Itoh, Yamamoto (bb0380) 2009; 15
Wang, Hayes, Henderson, Wolf (bb0570) 2007; 104
Lo, Matthews (bb0635) 2013; 270
Bensasson, Zoete, Dinkova-Kostova, Talalay (bb0185) 2008; 21
Ansell, Espinosa-Nicholas, Curran, Judy, Philips, Hannink, Lubahn (bb0620) 2004; 145
Zhou, Lo, Liu, Hannink, Lubahn (bb0675) 2007; 278
Gupta, Hevia, Patchva, Park, Koh, Aggarwal (bb0010) 2012; 16
Lu, Wardell, Burnstein, Defranco, Fuller, Giguere, Hochberg, McKay, Renoir, Weigel, Wilson, McDonnell, Cidlowski (bb0680) 2006; 58
Barbano, Muscarella, Pasculli, Valori, Fontana, Coco, la Torre, Balsamo, Poeta, Marangi, Maiello, Castelvetere, Pellegrini, Murgo, Fazio, Parrella (bb0480) 2013; 8
Kim, Kim, Cho, Lee, Kim (bb0750) 2012; 125
Kannan, Solovieva, Blank (bb0165) 2012; 1823
Xu, Huang, Shen, Yuan, Lin, Khor, Conney, Kong (bb0300) 2006; 66
Tong, Padmanabhan, Kobayashi, Shang, Hirotsu, Yokoyama, Yamamoto (bb0190) 2007; 27
Kwak, Itoh, Yamamoto, Sutter, Kensler (bb0305) 2001; 7
Luo, Sladek, Bader, Matthyssen, Rossant, Giguere (bb0650) 1997; 388
Brabender, Metzger, Salonga, Danenberg, Danenberg, Holscher, Schneider (bb0715) 2005; 26
Nioi, Nguyen, Sherratt, Pickett (bb0100) 2005; 25
Dey, Barros, Warner, Strom, Gustafsson (bb0615) 2013; 51
Brabender, Danenberg, Metzger, Schneider, Lord, Groshen, Tsao-Wei, Park, Salonga, Holscher, Danenberg (bb0705) 2002; 8
Iida, Itoh, Kumagai, Oyasu, Hattori, Kawai, Shimazui, Akaza, Yamamoto (bb0295) 2004; 64
Singh, Misra, Thimmulappa, Lee, Ames, Hoque, Herman, Baylin, Sidransky, Gabrielson, Brock, Biswal (bb0425) 2006; 3
Aoki, Sato, Nishimura, Takahashi, Itoh, Yamamoto (bb0310) 2001; 173
Singh, Happel, Manna, Acquaah-Mensah, Carrerero, Kumar, Nasipuri, Krausz, Wakabayashi, Dewi, Boros, Gonzalez, Gabrielson, Wong, Girnun, Biswal (bb0280) 2013; 123
Komatsu, Kurokawa, Waguri, Taguchi, Kobayashi, Ichimura, Sou, Ueno, Sakamoto, Tong, Kim, Nishito, Iemura, Natsume, Ueno, Kominami, Motohashi, Tanaka, Yamamoto (bb0225) 2010; 12
Yao, Brodie, Davidson, Kensler, Zhou (bb0630) 2010; 124
Itoh, Chiba, Takahashi, Ishii, Igarashi, Katoh, Oyake, Hayashi, Satoh, Hatayama, Yamamoto, Nabeshima (bb0080) 1997; 236
Reuter, Gupta, Chaturvedi, Aggarwal (bb0015) 2010; 49
Zhang, Burch, Cooney, Lanz, Pereira, Wu, Gibbs, Weinstock, Wheeler (bb0515) 2004; 14
Kurokawa, Motohashi, Sueno, Kimura, Takagawa, Kanno, Yamamoto, Tanaka (bb0160) 2009; 29
Onishi, Peng, Poth, Lee, Chen, Alexis, de Melo, Chen, Blackshaw (bb0670) 2010; 107
Zipper, Mulcahy (bb0045) 2002; 277
Camp, James, Dawson, Yan, Davison, Houck, Tang, Zheng, Major, Moon (bb0240) 2012; 287
Wong, Yoshinaga, Monma, Ito, Niikura, Nagase, Yamamoto, Yaegashi (bb0450) 2011; 21
Zhang, Lo, Cross, Templeton, Hannink (bb0145) 2004; 24
Shibata, Kokubu, Gotoh, Ojima, Ohta, Yamamoto, Hirohashi (bb0445) 2008; 135
Pawlak, Lefebvre, Staels (bb0525) 2012; 12
Altucci, Leibowitz, Ogilvie, de Lera, Gronemeyer (bb0565) 2007; 6
Blank (bb0155) 2008; 376
Niture, Jaiswal (bb0370) 2013; 57
Brabender, Lord, Metzger, Park, Salonga, Danenberg, Holscher, Danenberg, Schneider (bb0710) 2004; 8
Arlt, Sebens, Krebs, Geismann, Grossmann, Kruse, Schreiber, Schafer (bb0790) 2013; 32
Li, Yu, Kong (bb0115) 2006; 281
Padmanabhan, Tong, Ohta, Nakamura, Scharlock, Ohtsuji, Kang, Kobayashi, Yokoyama, Yamamoto (bb0420) 2006; 21
Giguere (bb0510) 1999; 20
Waris, Ahsan (bb0005) 2006; 5
Sladek (bb0505) 2011; 334
Ramos-Gomez, Kwak, Dolan, Itoh, Yamamoto, Talalay, Kensler (bb0290) 2001; 98
Lujambio, Lowe (bb0255) 2012; 482
Sangokoya, Telen, Chi (bb0260) 2010; 116
Niture, Jaiswal (bb0075) 2011; 18
Fourquet, Guerois, Biard, Toledano (bb0180) 2010; 285
DeNicola, Karreth, Humpton, Gopinathan, Wei, Frese, Mangal, Yu, Yeo, Calhoun, Scrimieri, Winter, Hruban, Iacobuzio-Donahue, Kern, Blair, Tuveson (bb0350) 2011; 475
Tew (bb0355) 2011; 24
Xu, Yuan, Pan, Shen, Kim, Yu, Khor, Li, Ma, Kong (bb0200) 2006; 5
Maire, Alvarez, Shankaranarayanan, Lera, Bourguet, Gronemeyer (bb0560) 2012; 12
Nioi, Nguyen (bb0440) 2007; 362
Mitsuishi, Taguchi, Kawatani, Shibata, Nukiwa, Aburatani, Yamamoto, Motohashi (bb0360) 2012; 22
Eades, Yang, Yao, Zhang, Zhou (bb0270) 2011; 286
Dinkova-Kostova, Holtzclaw, Cole, Itoh, Wakabayashi, Katoh, Yamamoto, Talalay (bb0060) 2002; 99
Itoh, Mimura, Yamamoto (bb0040) 2010; 13
Rastinejad, Perlmann, Evans, Sigler (bb0500) 1995; 375
Niture, Jaiswal (bb0365) 2012; 287
Suzuki, Motohashi, Yamamoto (bb0730) 2013; 34
Itoh, Wakabayashi, Katoh, Ishii, Igarashi, Engel, Yamamoto (bb0070) 1999; 13
Almasan, Mangelsdorf, Ong, Wahl, Evans (bb0580) 1994; 20
Ren, Villeneuve, Jiang, Wu, Lau, Toppin, Zhang (bb0770) 2011; 108
Tong, Katoh, Kusunoki, Itoh, Tanaka, Yamamoto (bb0090) 2006; 26
Xiao, Wang, Chou (bb0520) 2013; 13
Faraonio, Vergara, Di Marzo, Pierantoni, Napolitano, Russo, Cimino (bb0740) 2006; 281
Katoh, Itoh, Yoshida, Miyagishi, Fukamizu, Yamamoto (bb0105) 2001; 6
Shibata, Saito, Kokubu, Suzuki, Yamamoto, Hirohashi (bb0410) 2010; 70
Li, Yu, Liu, Kim, Blank, Li, Kong (bb0170) 2008; 1783
Amann, Eichmuller, Schmidt, Bazhin (bb0540) 2011; 18
Copple, Lister, Obeng, Kitteringham, Jenkins, Layfield, Foster, Goldring, Park (bb0220) 2010; 285
Tang, Wang, Fan, Wu, Xin, Ren, Wang (bb0765) 2011; 50
Pi, Bai, Reece, Williams, Liu, Freeman, Fahl, Shugar, Liu, Qu, Collins, Waalkes (bb0205) 2007; 42
Mitsunaga, Araki, Mizusaki, Morohashi, Haruna, Nakagata, Giguere, Yamamura, Abe (bb0655) 2004; 121
Malhotra, Portales-Casamar, Singh, Srivastava, Arenillas, Happel, Shyr, Wakabayashi, Kensler, Wasserman, Biswal (bb0035) 2010; 38
Wang, Liu, Geng, Gao, Wu, Hai, Li, Luo, Hayes, Wang, Tang (bb0135) 2013; 73
Chen, Sun, Wang, Jiang, Huang, Fang, Zhang (bb0215) 2009; 34
Magesh, Chen, Hu (bb0320) 2012; 32
Volonte, Liu, Musille, Stoppani, Wakabayashi, Di, Lisanti, Kensler, Galbiati (bb0755) 2013; 24
Ansell, Lo, Newton, Espinosa-Nicholas, Zhang, Liu, Hannink, Lubahn (bb0625) 2005; 243
Gao, Ke, Shi, Sun, Chen (bb0785) 2013; 206
Bain, Heneghan, Connaghan-Jones, Miura (bb0530) 2007; 69
Singh, Boldin-Adamsky, Thimmulappa, Rath, Ashush, Coulter, Blackford, Goodman, Bunz, Watson, Gabrielson, Feinstein, Biswal (bb0375) 2008; 68
Singh, Bodas, Wakabayashi, Bunz, Biswal (bb0390) 2010; 13
Deroo, Korach (bb0720) 2006; 116
Wang, Sun, Villeneuve, Zhang, Zhao, Li, Chen, Yi, Zheng, Wondrak, Wong, Zhang (bb0340) 2008; 29
Ikeda, Sugawara, Taniyama, Uru
Jain (10.1016/j.bbamcr.2014.05.003_bb0230) 2010; 285
Fourquet (10.1016/j.bbamcr.2014.05.003_bb0180) 2010; 285
Yamamoto (10.1016/j.bbamcr.2014.05.003_bb0055) 2008; 28
Kim (10.1016/j.bbamcr.2014.05.003_bb0110) 2013; 32
Malhotra (10.1016/j.bbamcr.2014.05.003_bb0035) 2010; 38
Eades (10.1016/j.bbamcr.2014.05.003_bb0270) 2011; 286
McMahon (10.1016/j.bbamcr.2014.05.003_bb0120) 2004; 279
Shibata (10.1016/j.bbamcr.2014.05.003_bb0445) 2008; 135
Niture (10.1016/j.bbamcr.2014.05.003_bb0365) 2012; 287
Almasan (10.1016/j.bbamcr.2014.05.003_bb0580) 1994; 20
Gronemeyer (10.1016/j.bbamcr.2014.05.003_bb0795) 2004; 3
Hayes (10.1016/j.bbamcr.2014.05.003_bb0150) 2010; 13
Deroo (10.1016/j.bbamcr.2014.05.003_bb0720) 2006; 116
Shibata (10.1016/j.bbamcr.2014.05.003_bb0395) 2008; 105
Oakley (10.1016/j.bbamcr.2014.05.003_bb0685) 2013; 132
Camp (10.1016/j.bbamcr.2014.05.003_bb0240) 2012; 287
Lujambio (10.1016/j.bbamcr.2014.05.003_bb0255) 2012; 482
Brabender (10.1016/j.bbamcr.2014.05.003_bb0715) 2005; 26
Luo (10.1016/j.bbamcr.2014.05.003_bb0650) 1997; 388
Niture (10.1016/j.bbamcr.2014.05.003_bb0370) 2013; 57
Kratschmar (10.1016/j.bbamcr.2014.05.003_bb0695) 2012; 7
Dhakshinamoorthy (10.1016/j.bbamcr.2014.05.003_bb0140) 2001; 20
Blank (10.1016/j.bbamcr.2014.05.003_bb0155) 2008; 376
Maire (10.1016/j.bbamcr.2014.05.003_bb0560) 2012; 12
Brabender (10.1016/j.bbamcr.2014.05.003_bb0710) 2004; 8
Ren (10.1016/j.bbamcr.2014.05.003_bb0770) 2011; 108
Wang (10.1016/j.bbamcr.2014.05.003_bb0460) 2008; 373
Niture (10.1016/j.bbamcr.2014.05.003_bb0075) 2011; 18
Dhakshinamoorthy (10.1016/j.bbamcr.2014.05.003_bb0735) 2005; 280
Venugopal (10.1016/j.bbamcr.2014.05.003_bb0285) 1996; 93
Moi (10.1016/j.bbamcr.2014.05.003_bb0020) 1994; 91
Tew (10.1016/j.bbamcr.2014.05.003_bb0355) 2011; 24
Dinkova-Kostova (10.1016/j.bbamcr.2014.05.003_bb0060) 2002; 99
Kannan (10.1016/j.bbamcr.2014.05.003_bb0165) 2012; 1823
Singh (10.1016/j.bbamcr.2014.05.003_bb0425) 2006; 3
Ohta (10.1016/j.bbamcr.2014.05.003_bb0430) 2008; 68
Kim (10.1016/j.bbamcr.2014.05.003_bb0400) 2010; 220
Ramos-Gomez (10.1016/j.bbamcr.2014.05.003_bb0290) 2001; 98
Kim (10.1016/j.bbamcr.2014.05.003_bb0750) 2012; 125
Arlt (10.1016/j.bbamcr.2014.05.003_bb0790) 2013; 32
Okano (10.1016/j.bbamcr.2014.05.003_bb0490) 2013; 8
Lo (10.1016/j.bbamcr.2014.05.003_bb0635) 2013; 270
Boesch-Saadatmandi (10.1016/j.bbamcr.2014.05.003_bb0760) 2009; 93
Homma (10.1016/j.bbamcr.2014.05.003_bb0380) 2009; 15
Komatsu (10.1016/j.bbamcr.2014.05.003_bb0225) 2010; 12
Sangokoya (10.1016/j.bbamcr.2014.05.003_bb0260) 2010; 116
Li (10.1016/j.bbamcr.2014.05.003_bb0170) 2008; 1783
Apopa (10.1016/j.bbamcr.2014.05.003_bb0210) 2008; 22
Hatcher (10.1016/j.bbamcr.2014.05.003_bb0330) 2008; 65
Tong (10.1016/j.bbamcr.2014.05.003_bb0190) 2007; 27
Padmanabhan (10.1016/j.bbamcr.2014.05.003_bb0420) 2006; 21
Krishnan (10.1016/j.bbamcr.2014.05.003_bb0725) 2007; 7
Muscarella (10.1016/j.bbamcr.2014.05.003_bb0465) 2011; 6
Singh (10.1016/j.bbamcr.2014.05.003_bb0345) 2010; 9
Giguere (10.1016/j.bbamcr.2014.05.003_bb0645) 2002; 13
Yu (10.1016/j.bbamcr.2014.05.003_bb0665) 2008; 27
Germain (10.1016/j.bbamcr.2014.05.003_bb0545) 2006; 58
Itoh (10.1016/j.bbamcr.2014.05.003_bb0080) 1997; 236
Zhou (10.1016/j.bbamcr.2014.05.003_bb0675) 2007; 278
Onishi (10.1016/j.bbamcr.2014.05.003_bb0670) 2010; 107
Watson (10.1016/j.bbamcr.2014.05.003_bb0550) 2012; 348
Dawson (10.1016/j.bbamcr.2014.05.003_bb0585) 2012; 1821
Rada (10.1016/j.bbamcr.2014.05.003_bb0125) 2011; 31
Singh (10.1016/j.bbamcr.2014.05.003_bb0390) 2010; 13
Copple (10.1016/j.bbamcr.2014.05.003_bb0220) 2010; 285
Magesh (10.1016/j.bbamcr.2014.05.003_bb0320) 2012; 32
Germain (10.1016/j.bbamcr.2014.05.003_bb0575) 2006; 58
Waris (10.1016/j.bbamcr.2014.05.003_bb0005) 2006; 5
Thimmulappa (10.1016/j.bbamcr.2014.05.003_bb0025) 2002; 62
Nioi (10.1016/j.bbamcr.2014.05.003_bb0100) 2005; 25
Li (10.1016/j.bbamcr.2014.05.003_bb0115) 2006; 281
Ahmadian (10.1016/j.bbamcr.2014.05.003_bb0600) 2013; 19
Mitsuishi (10.1016/j.bbamcr.2014.05.003_bb0360) 2012; 22
Gao (10.1016/j.bbamcr.2014.05.003_bb0785) 2013; 206
Suzuki (10.1016/j.bbamcr.2014.05.003_bb0730) 2013; 34
Zhang (10.1016/j.bbamcr.2014.05.003_bb0145) 2004; 24
Volonte (10.1016/j.bbamcr.2014.05.003_bb0755) 2013; 24
Lu (10.1016/j.bbamcr.2014.05.003_bb0680) 2006; 58
Li (10.1016/j.bbamcr.2014.05.003_bb0610) 2004; 24
Singh (10.1016/j.bbamcr.2014.05.003_bb0280) 2013; 123
Bain (10.1016/j.bbamcr.2014.05.003_bb0530) 2007; 69
Yao (10.1016/j.bbamcr.2014.05.003_bb0630) 2010; 124
Brown (10.1016/j.bbamcr.2014.05.003_bb0745) 2008; 68
Hanada (10.1016/j.bbamcr.2014.05.003_bb0475) 2012; 12
Itoh (10.1016/j.bbamcr.2014.05.003_bb0040) 2010; 13
Bushue (10.1016/j.bbamcr.2014.05.003_bb0535) 2010; 62
Sladek (10.1016/j.bbamcr.2014.05.003_bb0505) 2011; 334
Qu (10.1016/j.bbamcr.2014.05.003_bb0590) 2010; 65
Ma (10.1016/j.bbamcr.2014.05.003_bb0245) 2012; 32
Faraonio (10.1016/j.bbamcr.2014.05.003_bb0740) 2006; 281
Iida (10.1016/j.bbamcr.2014.05.003_bb0295) 2004; 64
Xu (10.1016/j.bbamcr.2014.05.003_bb0300) 2006; 66
Kwak (10.1016/j.bbamcr.2014.05.003_bb0305) 2001; 7
DeNicola (10.1016/j.bbamcr.2014.05.003_bb0350) 2011; 475
Muscarella (10.1016/j.bbamcr.2014.05.003_bb0470) 2011; 6
Amann (10.1016/j.bbamcr.2014.05.003_bb0540) 2011; 18
Ansell (10.1016/j.bbamcr.2014.05.003_bb0620) 2004; 145
Brabender (10.1016/j.bbamcr.2014.05.003_bb0705) 2002; 8
Helsen (10.1016/j.bbamcr.2014.05.003_bb0700) 2012; 348
Katoh (10.1016/j.bbamcr.2014.05.003_bb0095) 2005; 433
Bensasson (10.1016/j.bbamcr.2014.05.003_bb0185) 2008; 21
Wang (10.1016/j.bbamcr.2014.05.003_bb0135) 2013; 73
Wang (10.1016/j.bbamcr.2014.05.003_bb0340) 2008; 29
Pawlak (10.1016/j.bbamcr.2014.05.003_bb0525) 2012; 12
Wang (10.1016/j.bbamcr.2014.05.003_bb0570) 2007; 104
Huang (10.1016/j.bbamcr.2014.05.003_bb0195) 2000; 97
Chorley (10.1016/j.bbamcr.2014.05.003_bb0275) 2012; 40
Ansell (10.1016/j.bbamcr.2014.05.003_bb0625) 2005; 243
Gupta (10.1016/j.bbamcr.2014.05.003_bb0010) 2012; 16
Reuter (10.1016/j.bbamcr.2014.05.003_bb0015) 2010; 49
Shibata (10.1016/j.bbamcr.2014.05.003_bb0410) 2010; 70
Wong (10.1016/j.bbamcr.2014.05.003_bb0450) 2011; 21
Dey (10.1016/j.bbamcr.2014.05.003_bb0615) 2013; 51
Giguere (10.1016/j.bbamcr.2014.05.003_bb0640) 1988; 331
Giguere (10.1016/j.bbamcr.2014.05.003_bb0510) 1999; 20
Chen (10.1016/j.bbamcr.2014.05.003_bb0660) 2007; 13
Tang (10.1016/j.bbamcr.2014.05.003_bb0765) 2011; 50
Zipper (10.1016/j.bbamcr.2014.05.003_bb0045) 2002; 277
Zhang (10.1016/j.bbamcr.2014.05.003_bb0515) 2004; 14
Wakabayashi (10.1016/j.bbamcr.2014.05.003_bb0065) 2004; 101
Xu (10.1016/j.bbamcr.2014.05.003_bb0200) 2006; 5
Rastinejad (10.1016/j.bbamcr.2014.05.003_bb0500) 1995; 375
Katoh (10.1016/j.bbamcr.2014.05.003_bb0105) 2001; 6
Pi (10.1016/j.bbamcr.2014.05.003_bb0205) 2007; 42
Zhang (10.1016/j.bbamcr.2014.05.003_bb0335) 2008; 7
Ohnuma (10.1016/j.bbamcr.2014.05.003_bb0775) 2011; 413
Mitsunaga (10.1016/j.bbamcr.2014.05.003_bb0655) 2004; 121
Shibata (10.1016/j.bbamcr.2014.05.003_bb0405) 2011; 13
Germain (10.1016/j.bbamcr.2014.05.003_bb0495) 2006; 58
Singh (10.1016/j.bbamcr.2014.05.003_bb0375) 2008; 68
Plafker (10.1016/j.bbamcr.2014.05.003_bb0085) 2010; 285
Altucci (10.1016/j.bbamcr.2014.05.003_bb0565) 2007; 6
Hu (10.1016/j.bbamcr.2014.05.003_bb0415) 2012; 39
O'Malley (10.1016/j.bbamcr.2014.05.003_bb0555) 2009; 69
Sjoblom (10.1016/j.bbamcr.2014.05.003_bb0435) 2006; 314
Aoki (10.1016/j.bbamcr.2014.05.003_bb0310) 2001; 173
Lau (10.1016/j.bbamcr.2014.05.003_bb0235) 2010; 30
Ikeda (10.1016/j.bbamcr.2014.05.003_bb0605) 2000; 275
Suzuki (10.1016/j.bbamcr.2014.05.003_bb0485) 2013; 33
Tong (10.1016/j.bbamcr.2014.05.003_bb0090) 2006; 26
Kurokawa (10.1016/j.bbamcr.2014.05.003_bb0160) 2009; 29
Kundu (10.1016/j.bbamcr.2014.05.003_bb0030) 2010; 27
Chen (10.1016/j.bbamcr.2014.05.003_bb0215) 2009; 34
Furukawa (10.1016/j.bbamcr.2014.05.003_bb0050) 2005; 25
Cornblatt (10.1016/j.bbamcr.2014.05.003_bb0325) 2007; 28
Gao (10.1016/j.bbamcr.2014.05.003_bb0780) 2013; 34
Yang (10.1016/j.bbamcr.2014.05.003_bb0265) 2011; 129
Nioi (10.1016/j.bbamcr.2014.05.003_bb0440) 2007; 362
Itoh (10.1016/j.bbamcr.2014.05.003_bb0070) 1999; 13
Xiao (10.1016/j.bbamcr.2014.05.003_bb0520) 2013; 13
Berger (10.1016/j.bbamcr.2014.05.003_bb0595) 2002; 53
Ki (10.1016/j.bbamcr.2014.05.003_bb0690) 2005; 25
Zhang (10.1016/j.bbamcr.2014.05.003_bb0385) 2010; 9
Barbano (10.1016/j.bbamcr.2014.05.003_bb0480) 2013; 8
Hast (10.1016/j.bbamcr.2014.05.003_bb0250) 2013; 73
Chowdhry (10.1016/j.bbamcr.2014.05.003_bb0130) 2013; 32
Hong (10.1016/j.bbamcr.2014.05.003_bb0175) 2005; 18
Satoh (10.1016/j.bbamcr.2014.05.003_bb0315) 2010; 31
Li (10.1016/j.bbamcr.2014.05.003_bb0455) 2011; 56
References_xml – volume: 58
  start-page: 685
  year: 2006
  end-page: 704
  ident: bb0495
  article-title: Overview of nomenclature of nuclear receptors
  publication-title: Pharmacol. Rev.
  contributor:
    fullname: Laudet
– volume: 51
  start-page: T61
  year: 2013
  end-page: T74
  ident: bb0615
  article-title: Insight into the mechanisms of action of estrogen receptor beta in the breast, prostate, colon, and CNS
  publication-title: J. Mol. Endocrinol.
  contributor:
    fullname: Gustafsson
– volume: 62
  start-page: 1285
  year: 2010
  end-page: 1298
  ident: bb0535
  article-title: Retinoid pathway and cancer therapeutics
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Wan
– volume: 285
  start-page: 8463
  year: 2010
  end-page: 8471
  ident: bb0180
  article-title: Activation of NRF2 by nitrosative agents and H
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Toledano
– volume: 26
  start-page: 525
  year: 2005
  end-page: 530
  ident: bb0715
  article-title: Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis
  publication-title: Carcinogenesis
  contributor:
    fullname: Schneider
– volume: 25
  start-page: 10895
  year: 2005
  end-page: 10906
  ident: bb0100
  article-title: The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Pickett
– volume: 39
  start-page: 4743
  year: 2012
  end-page: 4747
  ident: bb0415
  article-title: Mutation of the Nrf2 gene in non-small cell lung cancer
  publication-title: Mol. Biol. Rep.
  contributor:
    fullname: Jiao
– volume: 19
  start-page: 557
  year: 2013
  end-page: 566
  ident: bb0600
  article-title: PPARgamma signaling and metabolism: the good, the bad and the future
  publication-title: Nat. Med.
  contributor:
    fullname: Evans
– volume: 13
  start-page: 1713
  year: 2010
  end-page: 1748
  ident: bb0150
  article-title: Cancer chemoprevention mechanisms mediated through the Keap1–Nrf2 pathway
  publication-title: Antioxid. Redox Signal.
  contributor:
    fullname: Dinkova-Kostova
– volume: 8
  start-page: e73794
  year: 2013
  ident: bb0490
  article-title: SNP (-617C>A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women
  publication-title: PLoS ONE
  contributor:
    fullname: Ishikawa
– volume: 50
  start-page: 1599
  year: 2011
  end-page: 1609
  ident: bb0765
  article-title: Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
  publication-title: Free Radic. Biol. Med.
  contributor:
    fullname: Wang
– volume: 25
  start-page: 162
  year: 2005
  end-page: 171
  ident: bb0050
  article-title: BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Xiong
– volume: 69
  start-page: 201
  year: 2007
  end-page: 220
  ident: bb0530
  article-title: Nuclear receptor structure: implications for function
  publication-title: Annu. Rev. Physiol.
  contributor:
    fullname: Miura
– volume: 31
  start-page: 1833
  year: 2010
  end-page: 1843
  ident: bb0315
  article-title: Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
  publication-title: Carcinogenesis
  contributor:
    fullname: Yamamoto
– volume: 388
  start-page: 778
  year: 1997
  end-page: 782
  ident: bb0650
  article-title: Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta
  publication-title: Nature
  contributor:
    fullname: Giguere
– volume: 91
  start-page: 9926
  year: 1994
  end-page: 9930
  ident: bb0020
  article-title: Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Kan
– volume: 93
  start-page: 14960
  year: 1996
  end-page: 14965
  ident: bb0285
  article-title: Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Jaiswal
– volume: 22
  start-page: 66
  year: 2012
  end-page: 79
  ident: bb0360
  article-title: Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming
  publication-title: Cancer Cell
  contributor:
    fullname: Motohashi
– volume: 7
  start-page: e36774
  year: 2012
  ident: bb0695
  article-title: Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11beta-HSD1-mediated glucocorticoid activation in hepatic cells
  publication-title: PLoS ONE
  contributor:
    fullname: Odermatt
– volume: 135
  start-page: 1358
  year: 2008
  end-page: 1368
  ident: bb0445
  article-title: Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer
  publication-title: Gastroenterology
  contributor:
    fullname: Hirohashi
– volume: 275
  start-page: 33142
  year: 2000
  end-page: 33150
  ident: bb0605
  article-title: Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Takeuchi
– volume: 413
  start-page: 623
  year: 2011
  end-page: 629
  ident: bb0775
  article-title: Enhanced sensitivity of A549 cells to the cytotoxic action of anticancer drugs via suppression of Nrf2 by procyanidins from Cinnamomi Cortex extract
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Hiratsuka
– volume: 32
  start-page: 687
  year: 2012
  end-page: 726
  ident: bb0320
  article-title: Small molecule modulators of Keap1–Nrf2–ARE pathway as potential preventive and therapeutic agents
  publication-title: Med. Res. Rev.
  contributor:
    fullname: Hu
– volume: 9
  start-page: 336
  year: 2010
  end-page: 346
  ident: bb0385
  article-title: Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Biswal
– volume: 105
  start-page: 13568
  year: 2008
  end-page: 13573
  ident: bb0395
  article-title: Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Hirohashi
– volume: 73
  start-page: 2199
  year: 2013
  end-page: 2210
  ident: bb0250
  article-title: Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination
  publication-title: Cancer Res.
  contributor:
    fullname: Major
– volume: 277
  start-page: 36544
  year: 2002
  end-page: 36552
  ident: bb0045
  article-title: The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Mulcahy
– volume: 18
  start-page: 1405
  year: 2011
  end-page: 1412
  ident: bb0540
  article-title: Regulation of gene expression by retinoids
  publication-title: Curr. Med. Chem.
  contributor:
    fullname: Bazhin
– volume: 58
  start-page: 760
  year: 2006
  end-page: 772
  ident: bb0575
  article-title: International Union of Pharmacology. LXIII. Retinoid X receptors
  publication-title: Pharmacol. Rev.
  contributor:
    fullname: Gronemeyer
– volume: 6
  start-page: 317
  year: 2011
  end-page: 325
  ident: bb0470
  article-title: Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome
  publication-title: Epigenetics
  contributor:
    fullname: Parrella
– volume: 7
  start-page: 532
  year: 2007
  end-page: 540
  ident: bb0725
  article-title: Biology of PPAR gamma in cancer: a critical review on existing lacunae
  publication-title: Curr. Mol. Med.
  contributor:
    fullname: Pillai
– volume: 285
  start-page: 22576
  year: 2010
  end-page: 22591
  ident: bb0230
  article-title: p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Johansen
– volume: 25
  start-page: 4150
  year: 2005
  end-page: 4165
  ident: bb0690
  article-title: Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Kim
– volume: 68
  start-page: 7975
  year: 2008
  end-page: 7984
  ident: bb0375
  article-title: RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
  publication-title: Cancer Res.
  contributor:
    fullname: Biswal
– volume: 121
  start-page: 237
  year: 2004
  end-page: 246
  ident: bb0655
  article-title: Loss of PGC-specific expression of the orphan nuclear receptor ERR-beta results in reduction of germ cell number in mouse embryos
  publication-title: Mech. Dev.
  contributor:
    fullname: Abe
– volume: 286
  start-page: 40725
  year: 2011
  end-page: 40733
  ident: bb0270
  article-title: miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Zhou
– volume: 375
  start-page: 203
  year: 1995
  end-page: 211
  ident: bb0500
  article-title: Structural determinants of nuclear receptor assembly on DNA direct repeats
  publication-title: Nature
  contributor:
    fullname: Sigler
– volume: 8
  start-page: 413
  year: 2004
  end-page: 422
  ident: bb0710
  article-title: Role of retinoid X receptor mRNA expression in Barrett's esophagus
  publication-title: J. Gastrointest. Surg.
  contributor:
    fullname: Schneider
– volume: 373
  start-page: 151
  year: 2008
  end-page: 154
  ident: bb0460
  article-title: Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Zhou
– volume: 1823
  start-page: 1841
  year: 2012
  end-page: 1846
  ident: bb0165
  article-title: The small MAF transcription factors MAFF, MAFG and MAFK: current knowledge and perspectives
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Blank
– volume: 108
  start-page: 1433
  year: 2011
  end-page: 1438
  ident: bb0770
  article-title: Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Zhang
– volume: 9
  start-page: 2365
  year: 2010
  end-page: 2376
  ident: bb0345
  article-title: Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Biswal
– volume: 34
  start-page: 663
  year: 2009
  end-page: 673
  ident: bb0215
  article-title: Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response
  publication-title: Mol. Cell
  contributor:
    fullname: Zhang
– volume: 31
  start-page: 1121
  year: 2011
  end-page: 1133
  ident: bb0125
  article-title: SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Cuadrado
– volume: 6
  start-page: 710
  year: 2011
  end-page: 719
  ident: bb0465
  article-title: Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
  publication-title: Epigenetics
  contributor:
    fullname: Fazio
– volume: 107
  start-page: 11579
  year: 2010
  end-page: 11584
  ident: bb0670
  article-title: The orphan nuclear hormone receptor ERRbeta controls rod photoreceptor survival
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Blackshaw
– volume: 5
  start-page: 1918
  year: 2006
  end-page: 1926
  ident: bb0200
  article-title: Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Kong
– volume: 33
  start-page: 2402
  year: 2013
  end-page: 2412
  ident: bb0485
  article-title: Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Yamamoto
– volume: 26
  start-page: 2887
  year: 2006
  end-page: 2900
  ident: bb0090
  article-title: Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Yamamoto
– volume: 101
  start-page: 2040
  year: 2004
  end-page: 2045
  ident: bb0065
  article-title: Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Talalay
– volume: 73
  start-page: 3097
  year: 2013
  end-page: 3108
  ident: bb0135
  article-title: RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2
  publication-title: Cancer Res.
  contributor:
    fullname: Tang
– volume: 243
  start-page: 27
  year: 2005
  end-page: 34
  ident: bb0625
  article-title: Repression of cancer protective genes by 17beta-estradiol: ligand-dependent interaction between human Nrf2 and estrogen receptor alpha
  publication-title: Mol. Cell. Endocrinol.
  contributor:
    fullname: Lubahn
– volume: 116
  start-page: 4338
  year: 2010
  end-page: 4348
  ident: bb0260
  article-title: MicroRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease
  publication-title: Blood
  contributor:
    fullname: Chi
– volume: 13
  start-page: 1192
  year: 2013
  end-page: 1200
  ident: bb0520
  article-title: Recent progresses in identifying nuclear receptors and their families
  publication-title: Curr. Top. Med. Chem.
  contributor:
    fullname: Chou
– volume: 29
  start-page: 1235
  year: 2008
  end-page: 1243
  ident: bb0340
  article-title: Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
  publication-title: Carcinogenesis
  contributor:
    fullname: Zhang
– volume: 123
  start-page: 2921
  year: 2013
  end-page: 2934
  ident: bb0280
  article-title: Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
  publication-title: J. Clin. Invest.
  contributor:
    fullname: Biswal
– volume: 34
  start-page: 1806
  year: 2013
  end-page: 1814
  ident: bb0780
  article-title: Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway
  publication-title: Carcinogenesis
  contributor:
    fullname: Chen
– volume: 285
  start-page: 16782
  year: 2010
  end-page: 16788
  ident: bb0220
  article-title: Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1–Nrf2 cell defense pathway
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Park
– volume: 21
  start-page: 1428
  year: 2011
  end-page: 1435
  ident: bb0450
  article-title: Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival
  publication-title: Int. J. Gynecol. Cancer
  contributor:
    fullname: Yaegashi
– volume: 287
  start-page: 6539
  year: 2012
  end-page: 6550
  ident: bb0240
  article-title: Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Moon
– volume: 285
  start-page: 23064
  year: 2010
  end-page: 23074
  ident: bb0085
  article-title: The ubiquitin-conjugating enzyme UbcM2 can regulate the stability and activity of the antioxidant transcription factor Nrf2
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Plafker
– volume: 18
  start-page: 1917
  year: 2005
  end-page: 1926
  ident: bb0175
  article-title: Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
  publication-title: Chem. Res. Toxicol.
  contributor:
    fullname: Liebler
– volume: 22
  start-page: 63
  year: 2008
  end-page: 76
  ident: bb0210
  article-title: Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells
  publication-title: J. Biochem. Mol. Toxicol.
  contributor:
    fullname: Ma
– volume: 7
  start-page: 3470
  year: 2008
  end-page: 3479
  ident: bb0335
  article-title: Dithiolethiones for cancer chemoprevention: where do we stand?
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Munday
– volume: 281
  start-page: 27251
  year: 2006
  end-page: 27263
  ident: bb0115
  article-title: Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Kong
– volume: 376
  start-page: 913
  year: 2008
  end-page: 925
  ident: bb0155
  article-title: Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?
  publication-title: J. Mol. Biol.
  contributor:
    fullname: Blank
– volume: 27
  start-page: 3313
  year: 2008
  end-page: 3328
  ident: bb0665
  article-title: Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer
  publication-title: Oncogene
  contributor:
    fullname: Chan
– volume: 433
  start-page: 342
  year: 2005
  end-page: 350
  ident: bb0095
  article-title: Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome
  publication-title: Arch. Biochem. Biophys.
  contributor:
    fullname: Yamamoto
– volume: 70
  start-page: 9095
  year: 2010
  end-page: 9105
  ident: bb0410
  article-title: Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway
  publication-title: Cancer Res.
  contributor:
    fullname: Hirohashi
– volume: 30
  start-page: 3275
  year: 2010
  end-page: 3285
  ident: bb0235
  article-title: A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Zhang
– volume: 99
  start-page: 11908
  year: 2002
  end-page: 11913
  ident: bb0060
  article-title: Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Talalay
– volume: 13
  start-page: 76
  year: 1999
  end-page: 86
  ident: bb0070
  article-title: Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain
  publication-title: Genes Dev.
  contributor:
    fullname: Yamamoto
– volume: 42
  start-page: 1797
  year: 2007
  end-page: 1806
  ident: bb0205
  article-title: Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2
  publication-title: Free Radic. Biol. Med.
  contributor:
    fullname: Waalkes
– volume: 362
  start-page: 816
  year: 2007
  end-page: 821
  ident: bb0440
  article-title: A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Nguyen
– volume: 97
  start-page: 12475
  year: 2000
  end-page: 12480
  ident: bb0195
  article-title: Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Pickett
– volume: 24
  start-page: 7681
  year: 2004
  end-page: 7694
  ident: bb0610
  article-title: Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Muyan
– volume: 314
  start-page: 268
  year: 2006
  end-page: 274
  ident: bb0435
  article-title: The consensus coding sequences of human breast and colorectal cancers
  publication-title: Science
  contributor:
    fullname: Velculescu
– volume: 12
  start-page: 486
  year: 2012
  end-page: 504
  ident: bb0525
  article-title: General molecular biology and architecture of nuclear receptors
  publication-title: Curr. Top. Med. Chem.
  contributor:
    fullname: Staels
– volume: 132
  start-page: 1033
  year: 2013
  end-page: 1044
  ident: bb0685
  article-title: The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease
  publication-title: J. Allergy Clin. Immunol.
  contributor:
    fullname: Cidlowski
– volume: 13
  start-page: 864
  year: 2011
  end-page: 873
  ident: bb0405
  article-title: NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer
  publication-title: Neoplasia
  contributor:
    fullname: Yamamoto
– volume: 348
  start-page: 411
  year: 2012
  end-page: 417
  ident: bb0700
  article-title: Structural basis for nuclear hormone receptor DNA binding
  publication-title: Mol. Cell. Endocrinol.
  contributor:
    fullname: Claessens
– volume: 270
  start-page: 139
  year: 2013
  end-page: 148
  ident: bb0635
  article-title: The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells
  publication-title: Toxicol. Appl. Pharmacol.
  contributor:
    fullname: Matthews
– volume: 12
  start-page: 505
  year: 2012
  end-page: 527
  ident: bb0560
  article-title: Retinoid receptors and therapeutic applications of RAR/RXR modulators
  publication-title: Curr. Top. Med. Chem.
  contributor:
    fullname: Gronemeyer
– volume: 32
  start-page: 1506
  year: 2012
  end-page: 1517
  ident: bb0245
  article-title: PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Xia
– volume: 1821
  start-page: 21
  year: 2012
  end-page: 56
  ident: bb0585
  article-title: The retinoid X receptors and their ligands
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Xia
– volume: 38
  start-page: 5718
  year: 2010
  end-page: 5734
  ident: bb0035
  article-title: Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Biswal
– volume: 8
  start-page: 105
  year: 2013
  end-page: 112
  ident: bb0480
  article-title: Aberrant Keap1 methylation in breast cancer and association with clinicopathological features
  publication-title: Epigenetics
  contributor:
    fullname: Parrella
– volume: 124
  start-page: 585
  year: 2010
  end-page: 591
  ident: bb0630
  article-title: Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer
  publication-title: Breast Cancer Res. Treat.
  contributor:
    fullname: Zhou
– volume: 3
  start-page: 950
  year: 2004
  end-page: 964
  ident: bb0795
  article-title: Principles for modulation of the nuclear receptor superfamily
  publication-title: Nat. Rev. Drug Discov.
  contributor:
    fullname: Laudet
– volume: 3
  start-page: e420
  year: 2006
  ident: bb0425
  article-title: Dysfunctional KEAP1–NRF2 interaction in non-small-cell lung cancer
  publication-title: PLoS Med.
  contributor:
    fullname: Biswal
– volume: 20
  start-page: 397
  year: 1994
  end-page: 403
  ident: bb0580
  article-title: Chromosomal localization of the human retinoid X receptors
  publication-title: Genomics
  contributor:
    fullname: Evans
– volume: 18
  start-page: 439
  year: 2011
  end-page: 451
  ident: bb0075
  article-title: INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis
  publication-title: Cell Death Differ.
  contributor:
    fullname: Jaiswal
– volume: 32
  start-page: 4825
  year: 2013
  end-page: 4835
  ident: bb0790
  article-title: Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity
  publication-title: Oncogene
  contributor:
    fullname: Schafer
– volume: 27
  start-page: 999
  year: 2010
  end-page: 1013
  ident: bb0030
  article-title: Nrf2–Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis
  publication-title: Pharm. Res.
  contributor:
    fullname: Surh
– volume: 66
  start-page: 8293
  year: 2006
  end-page: 8296
  ident: bb0300
  article-title: Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2
  publication-title: Cancer Res.
  contributor:
    fullname: Kong
– volume: 6
  start-page: 857
  year: 2001
  end-page: 868
  ident: bb0105
  article-title: Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription
  publication-title: Genes Cells
  contributor:
    fullname: Yamamoto
– volume: 58
  start-page: 712
  year: 2006
  end-page: 725
  ident: bb0545
  article-title: International Union of Pharmacology. LX. Retinoic acid receptors
  publication-title: Pharmacol. Rev.
  contributor:
    fullname: Gronemeyer
– volume: 116
  start-page: 561
  year: 2006
  end-page: 570
  ident: bb0720
  article-title: Estrogen receptors and human disease
  publication-title: J. Clin. Invest.
  contributor:
    fullname: Korach
– volume: 206
  start-page: 100
  year: 2013
  end-page: 108
  ident: bb0785
  article-title: Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway
  publication-title: Chem. Biol. Interact.
  contributor:
    fullname: Chen
– volume: 49
  start-page: 1603
  year: 2010
  end-page: 1616
  ident: bb0015
  article-title: Oxidative stress, inflammation, and cancer: how are they linked?
  publication-title: Free Radic. Biol. Med.
  contributor:
    fullname: Aggarwal
– volume: 65
  start-page: 201
  year: 2010
  end-page: 205
  ident: bb0590
  article-title: Bexarotene: a promising anticancer agent
  publication-title: Cancer Chemother. Pharmacol.
  contributor:
    fullname: Tang
– volume: 173
  start-page: 154
  year: 2001
  end-page: 160
  ident: bb0310
  article-title: Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
  publication-title: Toxicol. Appl. Pharmacol.
  contributor:
    fullname: Yamamoto
– volume: 20
  start-page: 3906
  year: 2001
  end-page: 3917
  ident: bb0140
  article-title: Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene
  publication-title: Oncogene
  contributor:
    fullname: Jaiswal
– volume: 53
  start-page: 409
  year: 2002
  end-page: 435
  ident: bb0595
  article-title: The mechanisms of action of PPARs
  publication-title: Annu. Rev. Med.
  contributor:
    fullname: Moller
– volume: 482
  start-page: 347
  year: 2012
  end-page: 355
  ident: bb0255
  article-title: The microcosmos of cancer
  publication-title: Nature
  contributor:
    fullname: Lowe
– volume: 15
  start-page: 3423
  year: 2009
  end-page: 3432
  ident: bb0380
  article-title: Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Yamamoto
– volume: 5
  start-page: 14
  year: 2006
  ident: bb0005
  article-title: Reactive oxygen species: role in the development of cancer and various chronic conditions
  publication-title: J. Carcinog.
  contributor:
    fullname: Ahsan
– volume: 16
  start-page: 1295
  year: 2012
  end-page: 1322
  ident: bb0010
  article-title: Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy
  publication-title: Antioxid. Redox Signal.
  contributor:
    fullname: Aggarwal
– volume: 21
  start-page: 805
  year: 2008
  end-page: 812
  ident: bb0185
  article-title: Two-step mechanism of induction of the gene expression of a prototypic cancer-protective enzyme by diphenols
  publication-title: Chem. Res. Toxicol.
  contributor:
    fullname: Talalay
– volume: 29
  start-page: 6232
  year: 2009
  end-page: 6244
  ident: bb0160
  article-title: Structural basis of alternative DNA recognition by Maf transcription factors
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Tanaka
– volume: 334
  start-page: 3
  year: 2011
  end-page: 13
  ident: bb0505
  article-title: What are nuclear receptor ligands?
  publication-title: Mol. Cell. Endocrinol.
  contributor:
    fullname: Sladek
– volume: 7
  start-page: 135
  year: 2001
  end-page: 145
  ident: bb0305
  article-title: Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione
  publication-title: Mol. Med.
  contributor:
    fullname: Kensler
– volume: 145
  start-page: 311
  year: 2004
  end-page: 317
  ident: bb0620
  article-title: In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens
  publication-title: Endocrinology
  contributor:
    fullname: Lubahn
– volume: 279
  start-page: 31556
  year: 2004
  end-page: 31567
  ident: bb0120
  article-title: Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Hayes
– volume: 62
  start-page: 5196
  year: 2002
  end-page: 5203
  ident: bb0025
  article-title: Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray
  publication-title: Cancer Res.
  contributor:
    fullname: Biswal
– volume: 28
  start-page: 2758
  year: 2008
  end-page: 2770
  ident: bb0055
  article-title: Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Yamamoto
– volume: 69
  start-page: 8217
  year: 2009
  end-page: 8222
  ident: bb0555
  article-title: Nuclear receptor coregulators in cancer biology
  publication-title: Cancer Res.
  contributor:
    fullname: Kumar
– volume: 56
  start-page: 230
  year: 2011
  end-page: 234
  ident: bb0455
  article-title: KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma
  publication-title: J. Hum. Genet.
  contributor:
    fullname: Gabrielson
– volume: 104
  start-page: 19589
  year: 2007
  end-page: 19594
  ident: bb0570
  article-title: Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Wolf
– volume: 1783
  start-page: 1847
  year: 2008
  end-page: 1856
  ident: bb0170
  article-title: Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif
  publication-title: Biochim. Biophys. Acta
  contributor:
    fullname: Kong
– volume: 220
  start-page: 446
  year: 2010
  end-page: 451
  ident: bb0400
  article-title: Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
  publication-title: J. Pathol.
  contributor:
    fullname: Lee
– volume: 6
  start-page: 793
  year: 2007
  end-page: 810
  ident: bb0565
  article-title: RAR and RXR modulation in cancer and metabolic disease
  publication-title: Nat. Rev. Drug Discov.
  contributor:
    fullname: Gronemeyer
– volume: 58
  start-page: 782
  year: 2006
  end-page: 797
  ident: bb0680
  article-title: International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors
  publication-title: Pharmacol. Rev.
  contributor:
    fullname: Cidlowski
– volume: 24
  start-page: 10941
  year: 2004
  end-page: 10953
  ident: bb0145
  article-title: Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Hannink
– volume: 12
  start-page: 66
  year: 2012
  ident: bb0475
  article-title: Methylation of the KEAP1 gene promoter region in human colorectal cancer
  publication-title: BMC Cancer
  contributor:
    fullname: Saijo
– volume: 65
  start-page: 1631
  year: 2008
  end-page: 1652
  ident: bb0330
  article-title: Curcumin: from ancient medicine to current clinical trials
  publication-title: Cell Mol. Life Sci.
  contributor:
    fullname: Torti
– volume: 13
  start-page: 220
  year: 2002
  end-page: 225
  ident: bb0645
  article-title: To ERR in the estrogen pathway
  publication-title: Trends Endocrinol. Metab.
  contributor:
    fullname: Giguere
– volume: 24
  start-page: 1078
  year: 2011
  end-page: 1079
  ident: bb0355
  article-title: NrF2 Keap1 as gatekeepers of redox homeostasis — do they prevent or cause cancer?
  publication-title: Pigment Cell Melanoma Res.
  contributor:
    fullname: Tew
– volume: 68
  start-page: 1303
  year: 2008
  end-page: 1309
  ident: bb0430
  article-title: Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth
  publication-title: Cancer Res.
  contributor:
    fullname: Hirohashi
– volume: 13
  start-page: 1627
  year: 2010
  end-page: 1637
  ident: bb0390
  article-title: Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance
  publication-title: Antioxid. Redox Signal.
  contributor:
    fullname: Biswal
– volume: 57
  start-page: 119
  year: 2013
  end-page: 131
  ident: bb0370
  article-title: Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance
  publication-title: Free Radic. Biol. Med.
  contributor:
    fullname: Jaiswal
– volume: 287
  start-page: 9873
  year: 2012
  end-page: 9886
  ident: bb0365
  article-title: Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Jaiswal
– volume: 13
  start-page: 325
  year: 2007
  end-page: 337
  ident: bb0660
  article-title: Estrogen-related receptor beta/NR3B2 controls epithelial cell fate and endolymph production by the stria vascularis
  publication-title: Dev. Cell
  contributor:
    fullname: Nathans
– volume: 13
  start-page: 1665
  year: 2010
  end-page: 1678
  ident: bb0040
  article-title: Discovery of the negative regulator of Nrf2, Keap1: a historical overview
  publication-title: Antioxid. Redox Signal.
  contributor:
    fullname: Yamamoto
– volume: 129
  start-page: 983
  year: 2011
  end-page: 991
  ident: bb0265
  article-title: MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism
  publication-title: Breast Cancer Res. Treat.
  contributor:
    fullname: Zhou
– volume: 28
  start-page: 1485
  year: 2007
  end-page: 1490
  ident: bb0325
  article-title: Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast
  publication-title: Carcinogenesis
  contributor:
    fullname: Visvanathan
– volume: 68
  start-page: 364
  year: 2008
  end-page: 368
  ident: bb0745
  article-title: Activating transcription factor 3 is a novel repressor of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2)-regulated stress pathway
  publication-title: Cancer Res.
  contributor:
    fullname: Freeman
– volume: 24
  start-page: 1852
  year: 2013
  end-page: 1862
  ident: bb0755
  article-title: Inhibition of nuclear factor-erythroid 2-related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence
  publication-title: Mol. Biol. Cell
  contributor:
    fullname: Galbiati
– volume: 278
  start-page: 52
  year: 2007
  end-page: 62
  ident: bb0675
  article-title: ERRbeta: a potent inhibitor of Nrf2 transcriptional activity
  publication-title: Mol. Cell. Endocrinol.
  contributor:
    fullname: Lubahn
– volume: 34
  start-page: 340
  year: 2013
  end-page: 346
  ident: bb0730
  article-title: Toward clinical application of the Keap1–Nrf2 pathway
  publication-title: Trends Pharmacol. Sci.
  contributor:
    fullname: Yamamoto
– volume: 125
  start-page: 1284
  year: 2012
  end-page: 1295
  ident: bb0750
  article-title: E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells
  publication-title: J. Cell Sci.
  contributor:
    fullname: Kim
– volume: 20
  start-page: 689
  year: 1999
  end-page: 725
  ident: bb0510
  article-title: Orphan nuclear receptors: from gene to function
  publication-title: Endocr. Rev.
  contributor:
    fullname: Giguere
– volume: 21
  start-page: 689
  year: 2006
  end-page: 700
  ident: bb0420
  article-title: Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
  publication-title: Mol. Cell
  contributor:
    fullname: Yamamoto
– volume: 64
  start-page: 6424
  year: 2004
  end-page: 6431
  ident: bb0295
  article-title: Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
  publication-title: Cancer Res.
  contributor:
    fullname: Yamamoto
– volume: 12
  start-page: 213
  year: 2010
  end-page: 223
  ident: bb0225
  article-title: The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
  publication-title: Nat. Cell Biol.
  contributor:
    fullname: Yamamoto
– volume: 348
  start-page: 440
  year: 2012
  end-page: 449
  ident: bb0550
  article-title: Nuclear hormone receptor co-repressors: structure and function
  publication-title: Mol. Cell. Endocrinol.
  contributor:
    fullname: Schwabe
– volume: 331
  start-page: 91
  year: 1988
  end-page: 94
  ident: bb0640
  article-title: Identification of a new class of steroid hormone receptors
  publication-title: Nature
  contributor:
    fullname: Evans
– volume: 281
  start-page: 39776
  year: 2006
  end-page: 39784
  ident: bb0740
  article-title: p53 suppresses the Nrf2-dependent transcription of antioxidant response genes
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Cimino
– volume: 32
  start-page: 3765
  year: 2013
  end-page: 3781
  ident: bb0130
  article-title: Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
  publication-title: Oncogene
  contributor:
    fullname: Hayes
– volume: 8
  start-page: 438
  year: 2002
  end-page: 443
  ident: bb0705
  article-title: The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Danenberg
– volume: 475
  start-page: 106
  year: 2011
  end-page: 109
  ident: bb0350
  article-title: Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
  publication-title: Nature
  contributor:
    fullname: Tuveson
– volume: 40
  start-page: 7416
  year: 2012
  end-page: 7429
  ident: bb0275
  article-title: Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Bell
– volume: 280
  start-page: 16891
  year: 2005
  end-page: 16900
  ident: bb0735
  article-title: Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Jaiswal
– volume: 32
  start-page: 514
  year: 2013
  end-page: 527
  ident: bb0110
  article-title: The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains
  publication-title: Oncogene
  contributor:
    fullname: Kong
– volume: 27
  start-page: 7511
  year: 2007
  end-page: 7521
  ident: bb0190
  article-title: Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Yamamoto
– volume: 14
  start-page: 580
  year: 2004
  end-page: 590
  ident: bb0515
  article-title: Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome
  publication-title: Genome Res.
  contributor:
    fullname: Wheeler
– volume: 98
  start-page: 3410
  year: 2001
  end-page: 3415
  ident: bb0290
  article-title: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  contributor:
    fullname: Kensler
– volume: 93
  start-page: 547
  year: 2009
  end-page: 554
  ident: bb0760
  article-title: Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells
  publication-title: J. Anim. Physiol. Anim. Nutr. (Berl.)
  contributor:
    fullname: Rimbach
– volume: 236
  start-page: 313
  year: 1997
  end-page: 322
  ident: bb0080
  article-title: An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Nabeshima
– volume: 62
  start-page: 1285
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0535
  article-title: Retinoid pathway and cancer therapeutics
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2010.07.003
  contributor:
    fullname: Bushue
– volume: 124
  start-page: 585
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0630
  article-title: Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-010-1023-8
  contributor:
    fullname: Yao
– volume: 27
  start-page: 7511
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0190
  article-title: Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00753-07
  contributor:
    fullname: Tong
– volume: 3
  start-page: 950
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0795
  article-title: Principles for modulation of the nuclear receptor superfamily
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd1551
  contributor:
    fullname: Gronemeyer
– volume: 57
  start-page: 119
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0370
  article-title: Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2012.12.014
  contributor:
    fullname: Niture
– volume: 7
  start-page: 135
  year: 2001
  ident: 10.1016/j.bbamcr.2014.05.003_bb0305
  article-title: Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione
  publication-title: Mol. Med.
  doi: 10.1007/BF03401947
  contributor:
    fullname: Kwak
– volume: 3
  start-page: e420
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0425
  article-title: Dysfunctional KEAP1–NRF2 interaction in non-small-cell lung cancer
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.0030420
  contributor:
    fullname: Singh
– volume: 1823
  start-page: 1841
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0165
  article-title: The small MAF transcription factors MAFF, MAFG and MAFK: current knowledge and perspectives
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamcr.2012.06.012
  contributor:
    fullname: Kannan
– volume: 362
  start-page: 816
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0440
  article-title: A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2007.08.051
  contributor:
    fullname: Nioi
– volume: 24
  start-page: 1852
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0755
  article-title: Inhibition of nuclear factor-erythroid 2-related factor (Nrf2) by caveolin-1 promotes stress-induced premature senescence
  publication-title: Mol. Biol. Cell
  doi: 10.1091/mbc.E12-09-0666
  contributor:
    fullname: Volonte
– volume: 24
  start-page: 7681
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0610
  article-title: Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.24.17.7681-7694.2004
  contributor:
    fullname: Li
– volume: 413
  start-page: 623
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0775
  article-title: Enhanced sensitivity of A549 cells to the cytotoxic action of anticancer drugs via suppression of Nrf2 by procyanidins from Cinnamomi Cortex extract
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2011.09.014
  contributor:
    fullname: Ohnuma
– volume: 21
  start-page: 1428
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0450
  article-title: Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival
  publication-title: Int. J. Gynecol. Cancer
  doi: 10.1097/IGC.0b013e31822d0eb2
  contributor:
    fullname: Wong
– volume: 135
  start-page: 1358
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0445
  article-title: Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.06.082
  contributor:
    fullname: Shibata
– volume: 32
  start-page: 3765
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0130
  article-title: Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
  publication-title: Oncogene
  doi: 10.1038/onc.2012.388
  contributor:
    fullname: Chowdhry
– volume: 8
  start-page: e73794
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0490
  article-title: SNP (-617C>A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0073794
  contributor:
    fullname: Okano
– volume: 123
  start-page: 2921
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0280
  article-title: Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI66353
  contributor:
    fullname: Singh
– volume: 34
  start-page: 663
  year: 2009
  ident: 10.1016/j.bbamcr.2014.05.003_bb0215
  article-title: Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2009.04.029
  contributor:
    fullname: Chen
– volume: 42
  start-page: 1797
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0205
  article-title: Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2007.03.001
  contributor:
    fullname: Pi
– volume: 12
  start-page: 486
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0525
  article-title: General molecular biology and architecture of nuclear receptors
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/156802612799436641
  contributor:
    fullname: Pawlak
– volume: 58
  start-page: 712
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0545
  article-title: International Union of Pharmacology. LX. Retinoic acid receptors
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.58.4.4
  contributor:
    fullname: Germain
– volume: 28
  start-page: 2758
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0055
  article-title: Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.01704-07
  contributor:
    fullname: Yamamoto
– volume: 58
  start-page: 685
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0495
  article-title: Overview of nomenclature of nuclear receptors
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.58.4.2
  contributor:
    fullname: Germain
– volume: 6
  start-page: 793
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0565
  article-title: RAR and RXR modulation in cancer and metabolic disease
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2397
  contributor:
    fullname: Altucci
– volume: 69
  start-page: 8217
  year: 2009
  ident: 10.1016/j.bbamcr.2014.05.003_bb0555
  article-title: Nuclear receptor coregulators in cancer biology
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-2223
  contributor:
    fullname: O'Malley
– volume: 16
  start-page: 1295
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0010
  article-title: Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2011.4414
  contributor:
    fullname: Gupta
– volume: 93
  start-page: 14960
  year: 1996
  ident: 10.1016/j.bbamcr.2014.05.003_bb0285
  article-title: Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.93.25.14960
  contributor:
    fullname: Venugopal
– volume: 20
  start-page: 3906
  year: 2001
  ident: 10.1016/j.bbamcr.2014.05.003_bb0140
  article-title: Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204506
  contributor:
    fullname: Dhakshinamoorthy
– volume: 20
  start-page: 397
  year: 1994
  ident: 10.1016/j.bbamcr.2014.05.003_bb0580
  article-title: Chromosomal localization of the human retinoid X receptors
  publication-title: Genomics
  doi: 10.1006/geno.1994.1193
  contributor:
    fullname: Almasan
– volume: 15
  start-page: 3423
  year: 2009
  ident: 10.1016/j.bbamcr.2014.05.003_bb0380
  article-title: Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-08-2822
  contributor:
    fullname: Homma
– volume: 279
  start-page: 31556
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0120
  article-title: Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M403061200
  contributor:
    fullname: McMahon
– volume: 13
  start-page: 864
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0405
  article-title: NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer
  publication-title: Neoplasia
  doi: 10.1593/neo.11750
  contributor:
    fullname: Shibata
– volume: 13
  start-page: 1713
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0150
  article-title: Cancer chemoprevention mechanisms mediated through the Keap1–Nrf2 pathway
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2010.3221
  contributor:
    fullname: Hayes
– volume: 68
  start-page: 1303
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0430
  article-title: Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-5003
  contributor:
    fullname: Ohta
– volume: 314
  start-page: 268
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0435
  article-title: The consensus coding sequences of human breast and colorectal cancers
  publication-title: Science
  doi: 10.1126/science.1133427
  contributor:
    fullname: Sjoblom
– volume: 14
  start-page: 580
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0515
  article-title: Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome
  publication-title: Genome Res.
  doi: 10.1101/gr.2160004
  contributor:
    fullname: Zhang
– volume: 13
  start-page: 325
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0660
  article-title: Estrogen-related receptor beta/NR3B2 controls epithelial cell fate and endolymph production by the stria vascularis
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2007.07.011
  contributor:
    fullname: Chen
– volume: 6
  start-page: 857
  year: 2001
  ident: 10.1016/j.bbamcr.2014.05.003_bb0105
  article-title: Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription
  publication-title: Genes Cells
  doi: 10.1046/j.1365-2443.2001.00469.x
  contributor:
    fullname: Katoh
– volume: 13
  start-page: 76
  year: 1999
  ident: 10.1016/j.bbamcr.2014.05.003_bb0070
  article-title: Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain
  publication-title: Genes Dev.
  doi: 10.1101/gad.13.1.76
  contributor:
    fullname: Itoh
– volume: 26
  start-page: 2887
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0090
  article-title: Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.26.8.2887-2900.2006
  contributor:
    fullname: Tong
– volume: 236
  start-page: 313
  year: 1997
  ident: 10.1016/j.bbamcr.2014.05.003_bb0080
  article-title: An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1997.6943
  contributor:
    fullname: Itoh
– volume: 27
  start-page: 3313
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0665
  article-title: Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210986
  contributor:
    fullname: Yu
– volume: 27
  start-page: 999
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0030
  article-title: Nrf2–Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-010-0096-8
  contributor:
    fullname: Kundu
– volume: 376
  start-page: 913
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0155
  article-title: Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2007.11.074
  contributor:
    fullname: Blank
– volume: 220
  start-page: 446
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0400
  article-title: Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
  publication-title: J. Pathol.
  doi: 10.1002/path.2653
  contributor:
    fullname: Kim
– volume: 125
  start-page: 1284
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0750
  article-title: E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells
  publication-title: J. Cell Sci.
  doi: 10.1242/jcs.095422
  contributor:
    fullname: Kim
– volume: 32
  start-page: 4825
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0790
  article-title: Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity
  publication-title: Oncogene
  doi: 10.1038/onc.2012.493
  contributor:
    fullname: Arlt
– volume: 108
  start-page: 1433
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0770
  article-title: Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1014275108
  contributor:
    fullname: Ren
– volume: 12
  start-page: 213
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0225
  article-title: The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2021
  contributor:
    fullname: Komatsu
– volume: 285
  start-page: 22576
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0230
  article-title: p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.118976
  contributor:
    fullname: Jain
– volume: 58
  start-page: 782
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0680
  article-title: International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.58.4.9
  contributor:
    fullname: Lu
– volume: 65
  start-page: 201
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0590
  article-title: Bexarotene: a promising anticancer agent
  publication-title: Cancer Chemother. Pharmacol.
  doi: 10.1007/s00280-009-1140-4
  contributor:
    fullname: Qu
– volume: 285
  start-page: 16782
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0220
  article-title: Physical and functional interaction of sequestosome 1 with Keap1 regulates the Keap1–Nrf2 cell defense pathway
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.096545
  contributor:
    fullname: Copple
– volume: 25
  start-page: 4150
  year: 2005
  ident: 10.1016/j.bbamcr.2014.05.003_bb0690
  article-title: Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.25.10.4150-4165.2005
  contributor:
    fullname: Ki
– volume: 24
  start-page: 10941
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0145
  article-title: Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.24.24.10941-10953.2004
  contributor:
    fullname: Zhang
– volume: 40
  start-page: 7416
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0275
  article-title: Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gks409
  contributor:
    fullname: Chorley
– volume: 19
  start-page: 557
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0600
  article-title: PPARgamma signaling and metabolism: the good, the bad and the future
  publication-title: Nat. Med.
  doi: 10.1038/nm.3159
  contributor:
    fullname: Ahmadian
– volume: 145
  start-page: 311
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0620
  article-title: In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens
  publication-title: Endocrinology
  doi: 10.1210/en.2003-0817
  contributor:
    fullname: Ansell
– volume: 13
  start-page: 1192
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0520
  article-title: Recent progresses in identifying nuclear receptors and their families
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/15680266113139990006
  contributor:
    fullname: Xiao
– volume: 281
  start-page: 39776
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0740
  article-title: p53 suppresses the Nrf2-dependent transcription of antioxidant response genes
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M605707200
  contributor:
    fullname: Faraonio
– volume: 9
  start-page: 336
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0385
  article-title: Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-09-0589
  contributor:
    fullname: Zhang
– volume: 20
  start-page: 689
  year: 1999
  ident: 10.1016/j.bbamcr.2014.05.003_bb0510
  article-title: Orphan nuclear receptors: from gene to function
  publication-title: Endocr. Rev.
  contributor:
    fullname: Giguere
– volume: 73
  start-page: 2199
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0250
  article-title: Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-4400
  contributor:
    fullname: Hast
– volume: 121
  start-page: 237
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0655
  article-title: Loss of PGC-specific expression of the orphan nuclear receptor ERR-beta results in reduction of germ cell number in mouse embryos
  publication-title: Mech. Dev.
  doi: 10.1016/j.mod.2004.01.006
  contributor:
    fullname: Mitsunaga
– volume: 62
  start-page: 5196
  year: 2002
  ident: 10.1016/j.bbamcr.2014.05.003_bb0025
  article-title: Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray
  publication-title: Cancer Res.
  contributor:
    fullname: Thimmulappa
– volume: 24
  start-page: 1078
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0355
  article-title: NrF2 Keap1 as gatekeepers of redox homeostasis — do they prevent or cause cancer?
  publication-title: Pigment Cell Melanoma Res.
  doi: 10.1111/j.1755-148X.2011.00913.x
  contributor:
    fullname: Tew
– volume: 6
  start-page: 317
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0470
  article-title: Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome
  publication-title: Epigenetics
  doi: 10.4161/epi.6.3.14408
  contributor:
    fullname: Muscarella
– volume: 56
  start-page: 230
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0455
  article-title: KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma
  publication-title: J. Hum. Genet.
  doi: 10.1038/jhg.2010.172
  contributor:
    fullname: Li
– volume: 13
  start-page: 220
  year: 2002
  ident: 10.1016/j.bbamcr.2014.05.003_bb0645
  article-title: To ERR in the estrogen pathway
  publication-title: Trends Endocrinol. Metab.
  doi: 10.1016/S1043-2760(02)00592-1
  contributor:
    fullname: Giguere
– volume: 65
  start-page: 1631
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0330
  article-title: Curcumin: from ancient medicine to current clinical trials
  publication-title: Cell Mol. Life Sci.
  doi: 10.1007/s00018-008-7452-4
  contributor:
    fullname: Hatcher
– volume: 107
  start-page: 11579
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0670
  article-title: The orphan nuclear hormone receptor ERRbeta controls rod photoreceptor survival
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1000102107
  contributor:
    fullname: Onishi
– volume: 482
  start-page: 347
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0255
  article-title: The microcosmos of cancer
  publication-title: Nature
  doi: 10.1038/nature10888
  contributor:
    fullname: Lujambio
– volume: 28
  start-page: 1485
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0325
  article-title: Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgm049
  contributor:
    fullname: Cornblatt
– volume: 39
  start-page: 4743
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0415
  article-title: Mutation of the Nrf2 gene in non-small cell lung cancer
  publication-title: Mol. Biol. Rep.
  doi: 10.1007/s11033-011-1266-4
  contributor:
    fullname: Hu
– volume: 25
  start-page: 162
  year: 2005
  ident: 10.1016/j.bbamcr.2014.05.003_bb0050
  article-title: BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.25.1.162-171.2005
  contributor:
    fullname: Furukawa
– volume: 31
  start-page: 1833
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0315
  article-title: Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgq105
  contributor:
    fullname: Satoh
– volume: 285
  start-page: 23064
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0085
  article-title: The ubiquitin-conjugating enzyme UbcM2 can regulate the stability and activity of the antioxidant transcription factor Nrf2
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M110.121913
  contributor:
    fullname: Plafker
– volume: 98
  start-page: 3410
  year: 2001
  ident: 10.1016/j.bbamcr.2014.05.003_bb0290
  article-title: Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.051618798
  contributor:
    fullname: Ramos-Gomez
– volume: 104
  start-page: 19589
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0570
  article-title: Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0709483104
  contributor:
    fullname: Wang
– volume: 32
  start-page: 687
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0320
  article-title: Small molecule modulators of Keap1–Nrf2–ARE pathway as potential preventive and therapeutic agents
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21257
  contributor:
    fullname: Magesh
– volume: 206
  start-page: 100
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0785
  article-title: Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2013.08.008
  contributor:
    fullname: Gao
– volume: 373
  start-page: 151
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0460
  article-title: Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2008.06.004
  contributor:
    fullname: Wang
– volume: 287
  start-page: 6539
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0240
  article-title: Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.316471
  contributor:
    fullname: Camp
– volume: 132
  start-page: 1033
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0685
  article-title: The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease
  publication-title: J. Allergy Clin. Immunol.
  doi: 10.1016/j.jaci.2013.09.007
  contributor:
    fullname: Oakley
– volume: 243
  start-page: 27
  year: 2005
  ident: 10.1016/j.bbamcr.2014.05.003_bb0625
  article-title: Repression of cancer protective genes by 17beta-estradiol: ligand-dependent interaction between human Nrf2 and estrogen receptor alpha
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2005.08.002
  contributor:
    fullname: Ansell
– volume: 8
  start-page: 438
  year: 2002
  ident: 10.1016/j.bbamcr.2014.05.003_bb0705
  article-title: The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Brabender
– volume: 116
  start-page: 561
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0720
  article-title: Estrogen receptors and human disease
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI27987
  contributor:
    fullname: Deroo
– volume: 12
  start-page: 66
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0475
  article-title: Methylation of the KEAP1 gene promoter region in human colorectal cancer
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-12-66
  contributor:
    fullname: Hanada
– volume: 7
  start-page: 532
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0725
  article-title: Biology of PPAR gamma in cancer: a critical review on existing lacunae
  publication-title: Curr. Mol. Med.
  doi: 10.2174/156652407781695765
  contributor:
    fullname: Krishnan
– volume: 5
  start-page: 1918
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0200
  article-title: Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-05-0497
  contributor:
    fullname: Xu
– volume: 433
  start-page: 342
  year: 2005
  ident: 10.1016/j.bbamcr.2014.05.003_bb0095
  article-title: Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/j.abb.2004.10.012
  contributor:
    fullname: Katoh
– volume: 66
  start-page: 8293
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0300
  article-title: Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-06-0300
  contributor:
    fullname: Xu
– volume: 50
  start-page: 1599
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0765
  article-title: Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2011.03.008
  contributor:
    fullname: Tang
– volume: 388
  start-page: 778
  year: 1997
  ident: 10.1016/j.bbamcr.2014.05.003_bb0650
  article-title: Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-beta
  publication-title: Nature
  doi: 10.1038/42022
  contributor:
    fullname: Luo
– volume: 1821
  start-page: 21
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0585
  article-title: The retinoid X receptors and their ligands
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbalip.2011.09.014
  contributor:
    fullname: Dawson
– volume: 13
  start-page: 1665
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0040
  article-title: Discovery of the negative regulator of Nrf2, Keap1: a historical overview
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2010.3222
  contributor:
    fullname: Itoh
– volume: 22
  start-page: 66
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0360
  article-title: Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.05.016
  contributor:
    fullname: Mitsuishi
– volume: 32
  start-page: 1506
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0245
  article-title: PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.06271-11
  contributor:
    fullname: Ma
– volume: 375
  start-page: 203
  year: 1995
  ident: 10.1016/j.bbamcr.2014.05.003_bb0500
  article-title: Structural determinants of nuclear receptor assembly on DNA direct repeats
  publication-title: Nature
  doi: 10.1038/375203a0
  contributor:
    fullname: Rastinejad
– volume: 18
  start-page: 439
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0075
  article-title: INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2010.114
  contributor:
    fullname: Niture
– volume: 97
  start-page: 12475
  year: 2000
  ident: 10.1016/j.bbamcr.2014.05.003_bb0195
  article-title: Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.220418997
  contributor:
    fullname: Huang
– volume: 105
  start-page: 13568
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0395
  article-title: Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0806268105
  contributor:
    fullname: Shibata
– volume: 25
  start-page: 10895
  year: 2005
  ident: 10.1016/j.bbamcr.2014.05.003_bb0100
  article-title: The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.25.24.10895-10906.2005
  contributor:
    fullname: Nioi
– volume: 285
  start-page: 8463
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0180
  article-title: Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M109.051714
  contributor:
    fullname: Fourquet
– volume: 12
  start-page: 505
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0560
  article-title: Retinoid receptors and therapeutic applications of RAR/RXR modulators
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/156802612799436687
  contributor:
    fullname: Maire
– volume: 331
  start-page: 91
  year: 1988
  ident: 10.1016/j.bbamcr.2014.05.003_bb0640
  article-title: Identification of a new class of steroid hormone receptors
  publication-title: Nature
  doi: 10.1038/331091a0
  contributor:
    fullname: Giguere
– volume: 281
  start-page: 27251
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0115
  article-title: Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M602746200
  contributor:
    fullname: Li
– volume: 38
  start-page: 5718
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0035
  article-title: Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkq212
  contributor:
    fullname: Malhotra
– volume: 29
  start-page: 6232
  year: 2009
  ident: 10.1016/j.bbamcr.2014.05.003_bb0160
  article-title: Structural basis of alternative DNA recognition by Maf transcription factors
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00708-09
  contributor:
    fullname: Kurokawa
– volume: 7
  start-page: e36774
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0695
  article-title: Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11beta-HSD1-mediated glucocorticoid activation in hepatic cells
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0036774
  contributor:
    fullname: Kratschmar
– volume: 1783
  start-page: 1847
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0170
  article-title: Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamcr.2008.05.024
  contributor:
    fullname: Li
– volume: 278
  start-page: 52
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0675
  article-title: ERRbeta: a potent inhibitor of Nrf2 transcriptional activity
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2007.08.011
  contributor:
    fullname: Zhou
– volume: 13
  start-page: 1627
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0390
  article-title: Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2010.3219
  contributor:
    fullname: Singh
– volume: 99
  start-page: 11908
  year: 2002
  ident: 10.1016/j.bbamcr.2014.05.003_bb0060
  article-title: Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.172398899
  contributor:
    fullname: Dinkova-Kostova
– volume: 68
  start-page: 7975
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0375
  article-title: RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-1401
  contributor:
    fullname: Singh
– volume: 129
  start-page: 983
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0265
  article-title: MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-011-1604-1
  contributor:
    fullname: Yang
– volume: 9
  start-page: 2365
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0345
  article-title: Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-10-0108
  contributor:
    fullname: Singh
– volume: 18
  start-page: 1405
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0540
  article-title: Regulation of gene expression by retinoids
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986711795029618
  contributor:
    fullname: Amann
– volume: 91
  start-page: 9926
  year: 1994
  ident: 10.1016/j.bbamcr.2014.05.003_bb0020
  article-title: Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.91.21.9926
  contributor:
    fullname: Moi
– volume: 21
  start-page: 805
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0185
  article-title: Two-step mechanism of induction of the gene expression of a prototypic cancer-protective enzyme by diphenols
  publication-title: Chem. Res. Toxicol.
  doi: 10.1021/tx7002883
  contributor:
    fullname: Bensasson
– volume: 275
  start-page: 33142
  year: 2000
  ident: 10.1016/j.bbamcr.2014.05.003_bb0605
  article-title: Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M002319200
  contributor:
    fullname: Ikeda
– volume: 73
  start-page: 3097
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0135
  article-title: RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-3386
  contributor:
    fullname: Wang
– volume: 53
  start-page: 409
  year: 2002
  ident: 10.1016/j.bbamcr.2014.05.003_bb0595
  article-title: The mechanisms of action of PPARs
  publication-title: Annu. Rev. Med.
  doi: 10.1146/annurev.med.53.082901.104018
  contributor:
    fullname: Berger
– volume: 30
  start-page: 3275
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0235
  article-title: A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00248-10
  contributor:
    fullname: Lau
– volume: 280
  start-page: 16891
  year: 2005
  ident: 10.1016/j.bbamcr.2014.05.003_bb0735
  article-title: Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M500166200
  contributor:
    fullname: Dhakshinamoorthy
– volume: 5
  start-page: 14
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0005
  article-title: Reactive oxygen species: role in the development of cancer and various chronic conditions
  publication-title: J. Carcinog.
  doi: 10.1186/1477-3163-5-14
  contributor:
    fullname: Waris
– volume: 8
  start-page: 413
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0710
  article-title: Role of retinoid X receptor mRNA expression in Barrett's esophagus
  publication-title: J. Gastrointest. Surg.
  doi: 10.1016/j.gassur.2004.02.007
  contributor:
    fullname: Brabender
– volume: 64
  start-page: 6424
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0295
  article-title: Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-04-1906
  contributor:
    fullname: Iida
– volume: 277
  start-page: 36544
  year: 2002
  ident: 10.1016/j.bbamcr.2014.05.003_bb0045
  article-title: The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M206530200
  contributor:
    fullname: Zipper
– volume: 287
  start-page: 9873
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0365
  article-title: Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.312694
  contributor:
    fullname: Niture
– volume: 70
  start-page: 9095
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0410
  article-title: Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-0384
  contributor:
    fullname: Shibata
– volume: 334
  start-page: 3
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0505
  article-title: What are nuclear receptor ligands?
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2010.06.018
  contributor:
    fullname: Sladek
– volume: 31
  start-page: 1121
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0125
  article-title: SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.01204-10
  contributor:
    fullname: Rada
– volume: 7
  start-page: 3470
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0335
  article-title: Dithiolethiones for cancer chemoprevention: where do we stand?
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-08-0625
  contributor:
    fullname: Zhang
– volume: 8
  start-page: 105
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0480
  article-title: Aberrant Keap1 methylation in breast cancer and association with clinicopathological features
  publication-title: Epigenetics
  doi: 10.4161/epi.23319
  contributor:
    fullname: Barbano
– volume: 32
  start-page: 514
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0110
  article-title: The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains
  publication-title: Oncogene
  doi: 10.1038/onc.2012.59
  contributor:
    fullname: Kim
– volume: 475
  start-page: 106
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0350
  article-title: Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
  publication-title: Nature
  doi: 10.1038/nature10189
  contributor:
    fullname: DeNicola
– volume: 286
  start-page: 40725
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0270
  article-title: miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M111.275495
  contributor:
    fullname: Eades
– volume: 58
  start-page: 760
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0575
  article-title: International Union of Pharmacology. LXIII. Retinoid X receptors
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.58.4.7
  contributor:
    fullname: Germain
– volume: 116
  start-page: 4338
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0260
  article-title: MicroRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease
  publication-title: Blood
  doi: 10.1182/blood-2009-04-214817
  contributor:
    fullname: Sangokoya
– volume: 34
  start-page: 340
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0730
  article-title: Toward clinical application of the Keap1–Nrf2 pathway
  publication-title: Trends Pharmacol. Sci.
  doi: 10.1016/j.tips.2013.04.005
  contributor:
    fullname: Suzuki
– volume: 34
  start-page: 1806
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0780
  article-title: Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgt108
  contributor:
    fullname: Gao
– volume: 101
  start-page: 2040
  year: 2004
  ident: 10.1016/j.bbamcr.2014.05.003_bb0065
  article-title: Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0307301101
  contributor:
    fullname: Wakabayashi
– volume: 29
  start-page: 1235
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0340
  article-title: Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgn095
  contributor:
    fullname: Wang
– volume: 348
  start-page: 440
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0550
  article-title: Nuclear hormone receptor co-repressors: structure and function
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2011.08.033
  contributor:
    fullname: Watson
– volume: 51
  start-page: T61
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0615
  article-title: Insight into the mechanisms of action of estrogen receptor beta in the breast, prostate, colon, and CNS
  publication-title: J. Mol. Endocrinol.
  doi: 10.1530/JME-13-0150
  contributor:
    fullname: Dey
– volume: 22
  start-page: 63
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0210
  article-title: Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells
  publication-title: J. Biochem. Mol. Toxicol.
  doi: 10.1002/jbt.20212
  contributor:
    fullname: Apopa
– volume: 270
  start-page: 139
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0635
  article-title: The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/j.taap.2013.03.029
  contributor:
    fullname: Lo
– volume: 348
  start-page: 411
  year: 2012
  ident: 10.1016/j.bbamcr.2014.05.003_bb0700
  article-title: Structural basis for nuclear hormone receptor DNA binding
  publication-title: Mol. Cell. Endocrinol.
  doi: 10.1016/j.mce.2011.07.025
  contributor:
    fullname: Helsen
– volume: 33
  start-page: 2402
  year: 2013
  ident: 10.1016/j.bbamcr.2014.05.003_bb0485
  article-title: Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00065-13
  contributor:
    fullname: Suzuki
– volume: 173
  start-page: 154
  year: 2001
  ident: 10.1016/j.bbamcr.2014.05.003_bb0310
  article-title: Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1006/taap.2001.9176
  contributor:
    fullname: Aoki
– volume: 26
  start-page: 525
  year: 2005
  ident: 10.1016/j.bbamcr.2014.05.003_bb0715
  article-title: Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgi006
  contributor:
    fullname: Brabender
– volume: 18
  start-page: 1917
  year: 2005
  ident: 10.1016/j.bbamcr.2014.05.003_bb0175
  article-title: Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
  publication-title: Chem. Res. Toxicol.
  doi: 10.1021/tx0502138
  contributor:
    fullname: Hong
– volume: 69
  start-page: 201
  year: 2007
  ident: 10.1016/j.bbamcr.2014.05.003_bb0530
  article-title: Nuclear receptor structure: implications for function
  publication-title: Annu. Rev. Physiol.
  doi: 10.1146/annurev.physiol.69.031905.160308
  contributor:
    fullname: Bain
– volume: 49
  start-page: 1603
  year: 2010
  ident: 10.1016/j.bbamcr.2014.05.003_bb0015
  article-title: Oxidative stress, inflammation, and cancer: how are they linked?
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2010.09.006
  contributor:
    fullname: Reuter
– volume: 6
  start-page: 710
  year: 2011
  ident: 10.1016/j.bbamcr.2014.05.003_bb0465
  article-title: Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer
  publication-title: Epigenetics
  doi: 10.4161/epi.6.6.15773
  contributor:
    fullname: Muscarella
– volume: 93
  start-page: 547
  year: 2009
  ident: 10.1016/j.bbamcr.2014.05.003_bb0760
  article-title: Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells
  publication-title: J. Anim. Physiol. Anim. Nutr. (Berl.)
  doi: 10.1111/j.1439-0396.2008.00838.x
  contributor:
    fullname: Boesch-Saadatmandi
– volume: 68
  start-page: 364
  year: 2008
  ident: 10.1016/j.bbamcr.2014.05.003_bb0745
  article-title: Activating transcription factor 3 is a novel repressor of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2)-regulated stress pathway
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-2170
  contributor:
    fullname: Brown
– volume: 21
  start-page: 689
  year: 2006
  ident: 10.1016/j.bbamcr.2014.05.003_bb0420
  article-title: Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2006.01.013
  contributor:
    fullname: Padmanabhan
SSID ssj0000475
ssj0025309
Score 2.4813175
SecondaryResourceType review_article
Snippet Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also known as Nfe2l2) plays a critical role in regulating cellular defense against electrophilic and...
SourceID crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 1875
SubjectTerms Animals
Cancer therapy
Carcinogenesis - metabolism
Carcinogenesis - pathology
Humans
KEAP1
Models, Biological
Neh7
Neoplasms - drug therapy
Neoplasms - metabolism
Neoplasms - pathology
NF-E2-Related Factor 2 - antagonists & inhibitors
NF-E2-Related Factor 2 - metabolism
NRF2
Nuclear receptor
Receptors, Cytoplasmic and Nuclear - metabolism
Signal Transduction
Title Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer
URI https://dx.doi.org/10.1016/j.bbamcr.2014.05.003
https://www.ncbi.nlm.nih.gov/pubmed/24851839
Volume 1843
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5aRfQiWl_1xR68xmqy2Wy82WJprfZQrfYWNrsbqGBaSkV68bc7k0fVgwieliRsEmZ3Z76Bb74BODOBK42vpYNYQDhcBR76QZE4ygquudFcZCJJ933RGfLbkT-qQKushSFaZeH7c5-eeeviTqOwZmM6HjceMgK9lCGmCJS2-1VYdRH94ulcvW4-9e6-HDIP_KXEN04oK-gymlccq1dNwqCXPJPwLLtn_RqhvoWf9hZsFriRXee_tg0Vm9ZgLe8kuajBeqts3LYDg_uJKZpysUnC-oO2y4imoajynFEL4ne1YPGCpaRlrGYMDWCn1HXninW_EcwZ4lmmaVfMdmHYvnlsdZyidYKjMZ-YO1IJEZsLGwrXIoTzMAppjqfXxrgaRIRJhPEUF1oZkSSCJ0a4JtTK90JlEjz2e7CSTlJ7AAzzId_VsTASw7kNpfRMYAPfSCsDhBNhHZzSXNE0V8iISurYS5SbNyLzRhc-KZHWIShtGv1Y6Qid-B8z9_MlWH6H9NgI4h3--51HsEFXOWvsGFbmszd7gjBjHp9C9fzj8rTYTDR2e50-jb3Bcw-fdkfNTz-m09k
link.rule.ids 315,783,787,3513,4509,24128,27581,27936,27937,45597,45675,45691,45886
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8JAEJ4gxujFKL7wuQevDdhut1tvSiSgwAEh4dZsd7cJJhZCMIZ_70wfiAdj4rXvzuzOfJN88w3ArQlcaXwtHcQCwuEq8DAOisRRVnDNjeYiE0nqD0RnzJ8n_qQCrbIXhmiVRezPY3oWrYsjjcKajfl02njNCPRShlgiUNnub8E2tV3SMu9OHr_DMQ_8tcA3Xl72z2UkrzhW75pkQe94JuBZzs76NT9tJJ_2AewXqJE95B92CBWb1mAnnyO5qsFuqxzbdgTD_swUI7nYLGGDYdtlRNJQ1HfOaADxp1qxeMVSUjJWC4a_b-c0c-eedTfo5QzRLNO0JhbHMG4_jVodpxic4GisJpaOVELEpmlD4VoEcB7mIM1x79oYfUE0mEQYT3GhlRFJInhihGtCrXwvVCbBTX8C1XSW2jNgWA35ro6FkZjMbSilZwIb-EZaGSCYCOvglOaK5rk-RlQSx96i3LwRmTdq-qRDWoegtGn0w88RhvA_7jzNXbB-D6mxEcA7__czb2C3M-r3ol538HIBe3Qm549dQnW5-LBXCDiW8XW2oL4ACunQeg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modulation+of+NRF2+signaling+pathway+by+nuclear+receptors%3A+implications+for+cancer&rft.jtitle=Biochimica+et+biophysica+acta&rft.au=Namani%2C+Akhileshwar&rft.au=Li%2C+Yulong&rft.au=Wang%2C+Xiu+Jun&rft.au=Tang%2C+Xiuwen&rft.date=2014-09-01&rft.issn=0006-3002&rft.volume=1843&rft.issue=9&rft.spage=1875&rft_id=info:doi/10.1016%2Fj.bbamcr.2014.05.003&rft_id=info%3Apmid%2F24851839&rft.externalDocID=24851839
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-4889&client=summon